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Kurzfassung   
 
Kurzfassung 
Die industrielle Herstellung von Massenprodukten erfolgt in vielen Branchen, wie 
beispielweise der Stahl-, Lebensmittel- oder petrochemischen Industrie, durch kontinuierliche 
Produktionsprozesse. Obwohl sie durch hohe Raum-Zeit-Ausbeuten, konstante Produkt-
qualitäten sowie geringere Rüstzeiten überzeugen, konnten sich kontinuierliche Prozesse für 
die biotechnologische Produktion von Pharmazeutika bislang nur sehr vereinzelt durchsetzen. 
Dies ist vor allem in einer erhöhten Komplexität der Verfahrensführung, einer gesteigerten 
Kontaminationsgefahr sowie strikten Regularien begründet. Zudem wird in 
biotechnologischen Prozessen meistens eine zusätzliche Apparatur zum Rückhalt von Zellen 
benötigt, um die Produktausbeute zu steigern und somit wirtschaftlich kompetitiv zu sein. 
Eine Verfahrensausführung zur kontinuierlichen biotechnologischen Produktion mit 
integrierter Produktabtrennung ist die gepulste Diafiltration. Bei diesem membran-basierten 
Zellrückhaltesystem wird das Membranmodul in die Kultivierungsflüssigkeit des Bioreaktors 
getaucht. Folglich verbleiben die Zellen in ihrer optimalen Umgebung und sind daher nur 
minimalen Scherkräften und keinen zusätzlichen Limitationen ausgesetzt. Über die getauchte 
Membran wird abwechselnd Produktlösung gewonnen und Medium zugeführt, so dass die 
mögliche Bildung einer Deckschicht auf der Membran reduziert wird. Die Etablierung der 
gepulsten Diafiltration sowie ihre Modifikation für verschiedene Anwendungsbereiche ist 
Gegenstand dieser Arbeit. 
Zunächst wurde das Membranmodul der gepulsten Diafiltration bezüglich seiner 
Biokompatibilität untersucht. Da in der Literatur keine standardisierten Verfahren zur 
Untersuchung der Biokompatibilität von Kunststoffen beschrieben sind, wurde im Rahmen 
dieser Arbeit ein solches Testverfahren entwickelt. Die Atmungsaktivität von 
Mikroorganismen wird bei diesem Biokompatibilitätstest in Abhängigkeit der Konzentration 
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der verwendeten Kunststoffteile mittels der RAMOS Technologie (Respiration Activity 
Monitoring System) untersucht. Es konnte festgestellt werden, dass 40 g L
-1
 Kabelbinder bzw. 
4 – 10 g L-1 Polyamidschlauch inhibierend auf die Hefe Hansenula polymorpha wirken, da 
das toxische Monomer 1,8-Diazacyclo-tetradecane-2,7-dione bzw. der Weichmacher N-
Butylbenzolsulfonamid aus den verwenden Kunststoffen auswäscht.  
Nach Gewährleistung der Biokompatibilität des Membranmoduls wurde die gepulste 
Diafiltration mit Fokus auf eine maximale Raum-Zeit-Ausbeute des Produktes sowie 
Langzeitstabilität des Filtrationsprozesses ausgelegt. Der gepulsten Diafiltration liegt eine 
Vier-Takt-Betriebsweise zugrunde, bei der zwischen Mediumszufuhr und Gewinnung der 
Produktlösung jeweils ein Zwischentakt zur Entleerung der Membran eingeführt worden ist. 
Durch gezielte Modifikation der Zwischentakte konnte verhindert werden, dass 
unverbrauchtes Medium in die Produktlösung gelangt. Das Resultat ist eine Steigerung der 
Raum-Zeit-Ausbeute sowie die Einsparung von Medium.  
Der Prozess gilt als langzeitstabil, wenn der kritische Flux, der zu einem Anstieg des 
Transmembrandrucks von 45 Pa min
-1
 führt, nicht überschritten wird. Mittels der Flux-Step 
Methode wurde der kritische Flux für die Kultivierung der Hefe H. polymorpha mit Syn6-
Medium bzw. der tierischen Zelllinie CHO DG44 mit Power CHO 2 Medium zu 21 L m
-2
 h
-1
 
bzw. 9 L m
-2
 h
-1
 bestimmt. Basierend auf diesen Daten wurde die benötige Membranfläche für 
eine langzeitstabile Anwendung beider Systeme abgeleitet.  
Eine erfolgreiche Demonstration der gepulsten Diafiltration ist sowohl für H. polymorpha, 
welche ein Antikörperfragment sezerniert, als auch für CHO Zellen, welche einen 
vollständigen Antikörper produzieren, in einen großen Durchflussratenbereich erfolgt. Im 
Vergleich zu einem konventionellen kontinuierlichen Prozess konnte die Antikörper-
produktion mittels H. polymorpha verdreifacht werden. In diesem Versuch hat die 
Antikörpertransmission über 80% betragen und die Vitalität aller Zellen ist konstant größer 
als 85% gewesen. Die Anwendung der gepulsten Diafiltration für CHO Zellen erzielte 
Antikörpertransmissionen von 40 – 60%. Dies ist ein in der Literatur üblicher Wert für 
membranbasierte Zellrückhaltesysteme. Über 90% der CHO Zellen waren während der 
gesamten Anwendung der gepulsten Diafiltration vital. In beiden Fermentationen war der 
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Transmembrandruck  über einen Zeitraum von mehr als drei Wochen unkritisch, so dass die 
gepulste Diafiltration als langzeitstabiler, kontinuierlicher Prozesse betrachtet werden kann. 
Die Betriebsweise der gepulsten Diafiltration verursacht zeitlich heterogene Bedingungen, da 
Überschuss und Limitation der C-Quelle abwechselnd vorliegen. Dieser kurzzeitige 
Überschuss kann insbesondere bei Mikroorganismen im höheren Durchflussratenbereich zu 
kurzzeitigen Sauerstofflimitationen führen. Unter diesen Bedingungen produziert 
H. polymorpha Ethanol und die Produktausbeute wird verringert. Für die in dieser Arbeit 
untersuchten künstlich induzierten kurzzeitigen Sauerstofflimitationen hat die Konzentration 
des Antikörpers um 25% abgenommen. Eine sequentielle Verwendung von drei Membranen 
ermöglicht eine quasi kontinuierliche Medienzufuhr, so dass konstante und nahezu homogene 
Kultivierungsbedingungen ohne Bildung von Ethanol bei gleichbleibender Produkt-
konzentration realisiert werden konnten.  
In dieser Arbeit hat sich die gepulste Diafiltration als robuster, langzeitstabiler und einfach 
umzusetzender Prozess zur in situ Produktgewinnung mit geringen Investmentkosten und 
minimalen Geräteaufwand erwiesen. Die Raum-Zeit-Ausbeute konnte deutlich gesteigert 
werden. Besonders vorteilhaft zeigte sich der Prozess bei scherempfindlichen Zellen und 
Organismen, welche Sauerstoff schnell verbrauchen.   
Kurzfassung 
 
Abstract 
 
Abstract 
Continuous processes are established in many industrial sectors such as steel, food or 
petrochemistry due to their cost effectiveness. Though they are characterized by their high 
space-time-yields, constant product quality as well as low downtimes, only a few continuous 
processes were implemented in the biotechnological pharmaceutical industry. This is caused 
by an increased complexity, a higher contamination risk and extensive regulations. 
Furthermore, in continuous biochemical engineered processes an additional cell retention 
system is required to achieve high product yields and to be economical competitive. In this 
regard, one option is the reverse-flow diafiltration, a membrane-based cell retention system. 
The membrane module is submerged in the bioreactor broth. Thus, cells are retained in their 
optimal environment minimizing shear stress and avoiding limitations such as oxygen. Over 
the submerged membrane product withdrawal and supply of fresh medium is alternated 
reducing a potential fouling layer. The objective of this work is to establish the reverse-flow 
diafiltration and modify its settings for different applications. 
At first, the membrane module was investigated regarding its biocompatibility. As there is no 
standardized analytical device or method to test biocompatibility, such a test method was 
developed within this work. The metabolic activity of various microorganisms was 
determined with the Respiration Activity MOnitoring Systems (RAMOS) as a function of the 
added amount of polymers commonly applied in biotechnology. Nylon and Polyamide 12, 
used in cable ties and tubing respectively, were found to delay and inhibit microbial growth. 
This is caused due to leaching of the plasticizer N-butylbenzenesulfonamide and the monomer 
1,8-Diazacyclotetradecane-2,7-dione, respectively, from the polymers. A metabolic activity 
inhibition threshold concentration between 4 – 10 g L-1 Polyamide 12 tubing and 
approximately 40 g L
-1
 Nylon was determined for the cultivation of the yeast Hansenula 
polymorpha, respectively.  
Abstract 
 
After the membrane module was proven to be biocompatible, a configuration of reverse-flow 
diafiltration was conducted with focus on maximization of space-time-yield and long-term 
filtration stability. Maximization resulted in an improved 4-step mode of operation. Between 
each alternation of product solution withdrawal and supply of fresh medium one intermediate 
step empties the membrane. The two intermediate steps were adjusted and, thus, mixing of 
permeate and fresh medium could be prevented. Hence, fresh medium was saved while 
simultaneously dilution of the product solution was avoided.  
Long-term stability is achieved if the critical flux is not exceeded which is reached at a critical 
transmembrane pressure increase of 45 Pa min
-1
. Optimal flux ranges for this process could be 
identified by a systematic flux step method: The critical flux for the yeast Hansenula 
polymorpha cultured in minimal Syn6 medium and the mammalian cell line CHO DG44 
cultured in Power CHO 2 medium is 21 L m
-2
 h
-1
 and 9 L m
-2
 h
-1
, respectively. The required 
membrane area for long-term stable processes is determined based on this data. 
Reverse-flow diafiltration was successfully applied over a broad range of dilution rates for 
both, the yeast H. polymorpha secreting a single-chain antibody and the mammalian cell line 
CHO DG44 secreting a full length antibody. The space-time-yield for H. polymorpha could 
be tripled in comparison to conventional continuous processes. Antibody transmission was 
above 80% and viability was constantly above 85% for this experiment. Application of 
reverse-flow diafiltration for CHO cells yields an antibody transmission between 40 and 60%, 
which is a typical value for membrane-based cell retention systems in literature. Viability was 
constantly above 90%. The transmembrane pressure was below the critical value for the 
culture time of over three weeks in both experiments indicating long-term stability. Thus, 
reverse-flow diafiltration proved to be an in situ cell retention device appropriate for 
cultivation of yeast and CHO cells.  
Conventional reverse-flow diafiltration pulses medium resulting in temporal heterogeneities. 
In microbial cultures especially the C-source alternates between depletion and excess, which 
leads to oscillations of the DOT signal. This effect is enforced at increased dilution rates. 
Artificially induced short-term oxygen limitations for H. polymorpha result in the formation 
of ethanol and a reduced product concentration of 25%. To overcome this cyclic problem, 
sequential operation of three membranes is introduced. Thus, quasi-continuous feeding is 
Abstract 
 
achieved reducing the oscillation of the DOT signal providing a nearly homogenous culture 
over time.  
 
In this thesis, reverse-flow diafiltration proved to be a fail-safe, long-term stable, easy 
applicable in situ product recovery process with low investment costs and minimal equipment 
requirements. Space-time-yields could be enhanced remarkably. RFD proved to be especially 
suitable for shear sensitive cells or organism prone to oxygen limitation. 
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Nomenclature 
Abbreviations 
1,8-DACTD-2,7-D 1,8-Diazacyclotetradecane-2,7-dione 
2,6-DTBP    2,6-Di-tert-butylphenol  
ATF    Alternating tangential flow system 
BCA    Bicinchoninic acid 
BSA    Bovine serum albumin 
C    Constant 
CHO    Chinese hamster ovary 
CFU    Colony forming units 
CSPR   Cell specific perfusion rate 
CTR    Carbon transfer rate [mmol L
-1
 h
-1
] 
DCW   Dry cell weight [g L
-1
] 
DHPS   Dihydropteroate Synthetase  
DOT    Dissolved oxygen tension [%] 
DTT    Dithiothreitol 
Nomenclature  VI 
 
EDTA   Ethylenediaminetetraacetic acid 
F    Free 
Fab    Fragment antigen binding 
Fc    Fragment crystallizable 
FPLC   Fast protein liquid chromatography 
GC-MS   Gas chromatography-mass spectrometry 
GMP    Good manufacturing practice 
H    Heavy 
H    Sample Harvest 
HC    Heavy chain 
HPLC   High performance liquid chromatography 
IgG    Immunoglobulin of type G 
L    Light 
LC    Light chain 
M    Marker 
MES    2-(N-morpholino)ethanesulfonic acid 
MF    Microfiltration 
MoBiDiK   Modulare Bioproduktion – Disposable und Kontinuierlich 
Nomenclature  VII 
 
MOPS   3-(N-morpholino)propanesulfonic acid 
NBBS   N-Butylbenzenesulfonamide 
Nylon   Polyamide 6.6 
OTR    Oxygen transfer rate [mmol L
-1
 h
-1
] 
OD600   Optical density measured at 600 nm 
PA    Polyamide 12 
PBS    Phosphate buffered saline 
PBST   Phosphate buffered saline tween 20 
PEEK   Polyether ether ketone 
PES    Polyethersulfone 
PI    Propidiumiodid 
PP    Polyproplyene 
PUR    Polyurethane 
R    Sample Reactor 
RAMOS   Respiration Activity Monitoring System 
RFD    Reverse-flow Diafiltration 
RQ    Respiration quotient [-] 
SDS    Sodium dodecyl sulfate polyacrylamide 
Nomenclature  VIII 
 
Teflon   Polytetrafluoroethylene  
TMP    Transmembrane pressure 
UV    Ultraviolet 
V    Variable 
YPG    Yeast extract peptone dextrose 
 
 
Roman Symbols 
a    Acceleration rate [h
-2
] 
aE    Emptying constant [-] 
aF    Flushing constant [-] 
AM    Outer membrane area [m²] 
AQ    Area of cross section [m²] 
BPA    Byproduct ammonium [g L
-1
] 
BPL    Byproduct lactate [g L
-1
] 
cAb,P    Antibody concentration in the permeate stream [g L
-1
] 
cAb,NF    Antibody concentration in the non-filtered product stream [g L
-1
] 
ccells    Concentration of cells [cells mL
-1
] 
Nomenclature  IX 
 
cS    Concentration of dye solution [g L
-1
] 
cS,f    Equilibrium dye concentration [g L
-1
] 
cS,i    Initial dye concentration [g L
-1
] 
cΨ    Concentration of Ψ [g L
-1
] 
D    Dilution rate [h
-1
 or d
-1
 for microbial or cell culture, respectively] 
dGlut    Degradation rate of glutamine [h
-1
] 
di    Inner diameter polymer tubing or membrane [mm] 
Dmax    Wash out point [h
-1
 or d
-1
 for microbial or cell culture, respectively] 
D0    Initial dilution rate for acceleration-stat mode [h
-1
] 
do    Outer diameter polymer tubing or membrane [mm]   
FF,E    Flux / specific feed flow rate at emptying step [L m
-2
 h
-1
] 
FF,F    Flux / specific feed flow rate at flushing step [L m
-2
 h
-1
] 
FF,Feed   Flux / specific feed flow rate at feed step [L m
-2
 h
-1
] 
FF,P    Flux / specific feed flow rate at permeate step [L m
-2
 h
-1
] 
FP,E    Flux / specific permeate flow rate at emptying step [L m
-2
 h
-1
] 
FP,F    Flux / specific permeate flow rate at flushing step [L m
-2
 h
-1
] 
FP,Feed   Flux / specific permeate flow rate at feed step [L m
-2
 h
-1
] 
FP,P    Flux / specific permeate flow rate at permeate step [L m
-2
 h
-1
] 
Nomenclature  X 
 
k    Constant for determination of viable cell density [-] 
kd    Constant for cell dying [h
-1
] 
kd,A    Half-maximum concentration of ammonium for cell death [g L
-1
] 
kd,L    Half-maximum concentration of lactate for cell death [g L
-1
] 
kM,A    Half-maximum concentration (Monod) constant ammonium [g L
-1
] 
kM,Gluc   Half-maximum concentration (Monod) constant glucose [g L
-1
] 
kM,Glut   Half-maximum concentration (Monod) constant glutamine [g L
-1
] 
kM,L    Half-maximum concentration (Monod) constant lactate [g L
-1
] 
L    Membrane length [m] 
mGluc    Maintenance coefficient glucose [10
-12
 mg L cells
-1
 h
-1
] 
mGlut    Maintenance coefficient glutamine [10
-12
 mg L cells
-1
 h
-1
] 
mM    Mass of absorbing mass [g]  
mX    Mass of biomass [g] 
n    Constant for determination of viable cell density [-] 
ncells    Number of cells [-] 
nsquare    Number of squares [-] 
NF    Non-filtered ratio [-] 
P    Product concentration [g L
-1
] 
Nomenclature  XI 
 
PX    Percentage of dead yeast cells [%] 
pmax    Maximal parameter for parameter estimation [-] 
pmin    Minimal parameter for parameter estimation [-] 
r    Randomly chosen value [-] 
rA    Removal rate of ammonium [h
-1
] 
SF,Gluc   Concentration of fed glucose [g L
-1
] 
SF,Glut    Concentration of fed glutamine [g L
-1
] 
SGluc    Concentration of substrate glucose [g L
-1
] 
SGlut    Concentration of substrate glutamine [g L
-1
] 
t    Time [h] 
tC    Cycle time [s] 
tE    Emptying step time [s] 
tF    Flushing step time [s] 
tFeed    Feeding step time [s] 
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Chapter 1 
1Introduction 
1.1 Biotechnological Production of Antibodies 
The demand for biopharmaceuticals has grown significantly over the last years. With a market 
share of 40%, monoclonal antibodies represent the most important product class of 
biopharmaceuticals (Walsh, 2010). Traditionally, antibodies are expressed in mammalian cell 
lines due to quality characteristics such as glycosylation and folding (Jostock, 2011). 
Especially Chinese hamster ovary cells (CHO cells) are often the production system of choice 
as they can be grown in suspensions suitable for high density cultures (Wurm, 2004). Genetic 
engineering tools for CHO cells are established and the risk of human virus transition is low 
(Cacciatore et al., 2010). However, cultivation of mammalian cells is time-consuming and 
accident-sensitive (Melmer et al., 2011). Furthermore, the medium is highly complex, 
expensive and often based on serum which is prone to contamination (Brunner et al., 2010).  
In the past years microbial expression systems for antibody production were investigated as 
they can grow faster, are more cost-efficient and can yield higher product concentrations (Zha 
et al., 2011). Recently, Ihssen et al. (2010) demonstrated an Escherichia coli (E.coli) strain 
expressing a suitable glycoprotein for vaccination. However, correct folding and 
glycosylation of antibodies produced in prokaryotes such as E. coli require a high degree of 
optimization if it is possible at all (Jostock, 2011). Eukaryotes such as yeast combine 
advantages of microbial and mammalian cells. They are capable of expressing correct folded 
proteins, are fast growing and robust. Furthermore, genetic engineering of yeasts is 
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established and proteins can be secreted into the medium, which simplifies purification 
(Melmer et al., 2011). Li et al. (2006) engineered a Pichia pastoris strain expressing a 
functional full length antibody. Though, these examples of functional expression of antibodies 
exist, glycosylation is limited in eukaryotes in comparison to mammalian cells (Ghaderi et al., 
2012). 
As discussed in this chapter, each organism has its advantages and drawbacks. Thus, 
depending on the application, the different organisms have to be traded against each other. A 
suitable cultivation system is capable of applying both. Hence, the cultivation system 
established in this work, a membrane bioreactor, should be adapted and put to test for both 
organisms, microbial and mammalian cells. 
 
 
 
Figure 1-1: (Single-chain) antibodies. A) Ribbon model of a full length antibody, B) 
Schematic drawing of a full length antibody C) Schematic drawing of a single-chain antibody. 
Fab: Fragment antigen binding Fc: Fragment crystallizable, C: Constant, V: Variable, L: 
Light, H: Heavy. Picture modified from Badrilla Ltd. (2014) 
 
 
 
Introduction  3 
  
 
1.2 Continuous and Perfusion Processes 
Industrial production of antibodies is mostly performed in batch or fed-batch mode. These 
established processes are particularly known for their reliable performance. However, 
continuous processes provide several advantages such as constant product quality, smaller 
equipment size, higher space-time-yields, lower downtime and faster adaption of cells to 
changing environments (Kuystermans and Al-Rubeai, 2011; Liang et al., 2013; Rodrigues et 
al., 2010; Su, 2010; Warikoo et al., 2012). In addition, integrated continuous processes 
applying cell retention are characterized by a higher product yield because the catalyst does 
have to be produced only once. Thus, continuous cell retention processes  have been 
extensively studied in the last years (Bleckwenn et al., 2005; Carstensen et al., 2013; Clincke 
et al., 2013a; Clincke et al., 2013b; Johnson et al., 1996; Meier et al., 2014; Trampler et al., 
1994), being economical and promising for production of monoclonal antibodies (Carstensen 
et al., 2012a; Castilho and Medronho, 2002; Konstantinov et al., 2006; Pollock et al., 2013; 
Warikoo et al., 2012). These processes were referred to as “perfusion processes” in 
mammalian cell technology and thus, also in this study if CHO cells are applied (Zeng and 
Sun, 2010). Apart from that, the term “continuous process applying cell retention” is used. 
In general, cell retention devices can be arranged external or internal. External devices can 
easily be connected to all kinds of bioreactors and exchanged if necessary. However, supply 
of nutrients such as oxygen is difficult and, thus, most often not conducted. Furthermore, 
shear stress in external devices is high, especially if cells are directed through pumps. Internal 
devices are characterized by their gentle treatment of cells. In internal devices cells are 
retained in the bioreactor and thus, in their optimal environment, which is advantageous for 
shear sensitive cells and microbial cultures prone to oxygen limitation. Recently, Carstensen 
et al. (2012a) and Jain et al. (2008) discussed the drawbacks and advantages of external and 
internal devices intensively in review publications.  
The main applied separation criteria in cell retention devices are size and density (Voisard et 
al., 2003). Cell retention devices based on density are for example hydrocyclones (Elsayed et 
al., 2006; Jockwer et al., 2001) and centrifuges (Johnson et al., 1996; Kim et al., 2007; 
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Takamatsu et al., 1996), both working with centrifugal forces, settlers (Choo et al., 2007; 
Hülscher et al., 1992; Pohlscheidt et al., 2013; Searles et al., 1994) using sedimentation 
properties and acoustic filters (Baptista et al., 2013; Dalm et al., 2005; Ryll et al., 2000), 
where an ultrasonic field enhances the sedimentation. Separation by means of size exclusion 
is conducted most often using filtration. State of the art implies hollow-fiber modules (Banik 
and Heath, 1995; Büntemeyer et al., 1987), cross-flow filtration devices (Caron et al., 1994; 
Delabroise et al., 1991; Kawahara et al., 1994) and rotating or spin-filters (Avgerinos et al., 
1990; Deo et al., 1996). Recent studies in literature often apply the ATF module (Alternating 
Tangential Flow, Refine Technology, New Jersey, USA) which is commercially available in 
several scales (Bleckwenn et al., 2005; Clincke et al., 2013b). The ATF process is based on 
the so-called “starling flow”. It works similarly to cross-flow operation and consists of two 
steps: In the first step suspension from the reactor is drawn through the inside of a hollow-
fiber membrane module into a diaphragm pump (Furey, 2000). In the next step the pump 
pushes the suspension back into the reactor. Hereby, an overpressure in the membrane leads 
to inside-out filtration. Backflush (outside-in) is induced by a temporary overpressure on the 
shell side. However, this overpressure exists only partly along the membrane length leading to 
a non-uniform reduction of the fouling layer. In addition, the module is externally located. 
Consequently, drawbacks of externally located modules occur for this device.  
Recently, reverse-flow diafiltration (RFD) was introduced as an internal or so called in situ 
membrane based product recovery and cell retention process for continuous and perfusion 
cultures (Carstensen et al., 2013; Carstensen et al., 2012b; Meier et al., 2014; Meier et al., 
May 2014). RFD alternates harvesting of product and feeding of fresh medium over the same 
submerged membrane enabling gentle cell retention while the formation of a fouling layer is 
minimized. However, alternation of harvesting and feeding results in a pulsed feeding of 
substrate. Therefore, concentrations of substrates fluctuate over time causing heterogeneous 
fermentation conditions. 
Heterogeneities in bioreactors were examined extensively in literature (Delafosse et al., 2010; 
Enfors et al., 2001; Hewitt and Nienow, 2007; Lara et al., 2006; Nienow, 2006; Xu et al., 
1999). The main focus of these studies was on large-scale bioreactors, where spatial 
heterogeneities of e.g. nutrients or the pH value occur due to poor mixing conditions at large 
scale. Hence, regions with high C-source concentrations and C-source-limited regions exist 
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simultaneously within the same bioreactor. Studies investigating heterogeneities of nutrients 
by applying glucose pulse experiments or bioreactors with poor mixed regions were 
conducted with Saccharomyces cerevisiae (Delvigne et al., 2006; George et al., 1993; Lejeune 
et al., 2013; Reijenga et al., 2005), Escherichia coli (Delvigne et al., 2009; Hewitt et al., 2007; 
Lara et al., 2009; Sunya et al., 2013) and other bacteria (Brooks and Meers, 1973; da Silva et 
al., 2008; Junne et al., 2011; Korneli et al., 2011; Schroeter et al., 2013) and yeast (Liang et 
al., 2013; Lorantfy et al., 2013). In these studies, it could be shown that overflow metabolites 
occur due to locally high substrate concentrations. Furthermore, short-term oxygen limitations 
of the microorganisms could be detected, causing a reduction of biomass and product 
concentration or the formation of overflow metabolites (Brooks and Meers, 1973; Enfors et 
al., 2001; George et al., 1993; Hewitt et al., 2007; Junne et al., 2011; Korneli et al., 2011; Lara 
et al., 2009; Lejeune et al., 2013; Lorantfy et al., 2013). However, also positive effects of 
short-term oxygen limitation could be noticed as the number of dead cells decreased (Enfors 
et al., 2001; Hewitt et al., 2007).  
 
 
Figure 1-2: Membrane bioreactor for Reverse-flow diafiltration with an integrated hollow-
fiber microfiltration membrane. 
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Continuous and perfusion cultures with externally arranged cell retention devices are prone to 
spatial heterogeneities as microorganisms are exposed to changing environmental conditions 
during passage through the device (Carstensen et al., 2012a). In contrast, cells are generally 
retained in their optimal environment in internally arranged cell retention devices. 
 
1.3 Qualification of Single-Use Materials in Bioreactors 
In the past fifty years, single-use technologies have become increasingly relevant in 
biomanufacturing (Ott, 2011; Sinclair and Monge, 2005). They are attractive, because they 
are more flexible in their applications, they minimize the risk of batch-to-batch contamination 
and they are cost-effective as a clean in place procedure is not necessary. Moreover, single-
use technologies can contribute to a reduction of the carbon footprint (Haxthausen, 2012). 
Composed of polymers as well as various processing aids and additives (McMillin, 1996), 
these single-use materials have raised concerns among scientists and manufactures of 
bioproducts. In particular, leaching of additives has been discussed as a major issue (Jenke, 
2007a; Skjevrak et al., 2005).  These additives can be toxic to humans and they may also 
adversely affect microorganism during culture.  
Although some regulations regarding the qualification of single-use materials exist 
(International Conference on Harmonization, 2000; International Organization for 
Standardization, 2009; Pharmaceutical Inspection Co-operation Scheme, 2007; US 
Pharmacopeia), a standardized method is not available to test the biocompatibility of such 
materials. Even though, manufactures of single-use components do certify their products after 
extensive investigation procedures, these procedures are often not comparable (Merseburger, 
2011). In addition, threshold concentrations of potentially harmful components leaching from 
polymer materials need to be defined as “safe”. This is highly complex, as the threshold 
concentrations are depending on the particular application  (Jenke, 2007b). In particular, 
single-use polymer bags (Eibl et al., 2011) and tubing (Jenke et al., 2006) have been 
developed and investigated regarding their biocompatibility. However, little is known about 
how leaching of polymer additives may affect microbial activity and compromise Good 
Manufacturing Practice (GMP).  
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1.4 The „MoBiDiK“ Project 
“Modulare Bioproduktion – Disposable und Kontinuierlich (MoBiDiK)” aims to realize a 
paradigm change from the established batch and fed-batch cultures to small, flexible and 
disposable continuous processes to meet the demand of patient- and disease-oriented 
biopharmaceuticals. By establishing a technology platform of continuous upstreaming and 
downstreaming processes the time-to market of newly developed biopharmaceuticals can be 
minimized and production becomes more economical. Furthermore, the shift between 
productions of different biopharmaceuticals can be conducted time-efficient as cleaning and 
down-times are reduced due to the disposable character of the equipment. Thus, patient can be 
treated with tailored biopharmaceuticals after a brief production time. 
The vision expressed in MoBiDiK results in the following requirements for an upstreaming 
process: A sterile, robust and biocompatible perfusion system should be developed. Long-
term stability with continuous high cell retention and antibody transmission must be proven. 
Antibody transmission is defined by the concentration of antibodies in the harvest dived by 
the concentration of antibodies in the bioreactor. Furthermore, the perfusion system should be 
small and producible as single-use system. Within the MoBiDiK project reverse-flow 
diafiltration was examined as one potential perfusion system. As the mention requirements 
were the basis of evaluation, they were also the main criteria considered within this thesis.  
  
1.5 Objectives and Overview 
Reverse-flow diafiltration (RFD) was first basically described by Carstensen et al. (2012b) 
applying model fluids. The potential of RFD in bioprocesses was exemplarily demonstrated 
for the recovery of itaconic acid produced by the fungus Ustilaog maydis (Carstensen et al., 
2013). One dilution rate was successfully applied. However, a broader range of dilution rates 
and long-term stability of the filtration process could not be shown yet. Furthermore, the 
applied bioreactor set-up of RFD developed within a cooperation project of Carstensen (2013) 
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and Klement (2013) was very basic. Thus, robust cultivations could not be performed. 
Moreover, in Carstensen et al. (2013) the product tank was diluted with unreacted substrate, 
leading to a loss of substrate, lower space-time-yields and more complicated purification.  
This thesis describes the efforts to establish RFD by improving the experimental set-up as 
well as settings and to broaden the scope of application through required modifications. 
Previous to the investigation of RFD, three analytical assays had to be established: First, 
single-use materials needed to be qualified for application in bioreactors. As the Respiration 
Activity MOnitoring Systems (RAMOS) has been proven to be a sensitive device to observe 
growth behavior as well as metabolic activities in general (Stöckmann et al., 2003), it was 
investigated whether biocompatibility tests for single-use materials can be conducted with the 
RAMOS device. Second and third, various methods to determine the concentration of the 
desired product, a single-chain antibody, as well as the viable cell density are investigated.  
In the subsequent chapter, optimizations of RFD settings are conducted based on 
mathematical calculations and experimental data. The target of this optimization step is to 
enhance space-time-yield significantly, prevent a loss of substrate and enable stable long term 
operation conditions. Furthermore, application and modification of RFD for the production of 
single-chain antibodies secreted by yeast as well as antibodies produced by mammalian cells 
is intended. Experiments applying conventional RFD with optimized settings are discussed 
for yeasts and mammalian cells in chapter 5. 
As experiments with mammalian cells are time-consuming and expensive, application of RFD 
for CHO cells is simulated. On the basis of the two experiments conducted and discussed in 
chapter 5, parameters of the CHO culture are estimated and a promising operation strategy is 
investigated in chapter 6. 
Conventional RFD is improved by realizing a quasi-continuous RFD in chapter 7. Temporally 
constant concentrations in the bioreactor were achieved by the sequential operation of three 
membranes. In the first part of the chapter, the pulsed feeding of RFD and its impact on the 
yeast H. polymorpha is investigated. In particular, fermentation conditions which result in 
repeated short-term oxygen limitations due to pulsed feeding were examined and compared to 
oxygen unlimited conditions. In the second part, a process scheme for sequential operation of 
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three membranes is introduced. The sequential operation is experimentally investigated for 
several dilution and stirring rates. 
Upon completion of this thesis RFD shall have a robust set-up with complete cell retention 
and constantly high antibody transmission. Long-term stable filtration performance shall be 
guaranteed and a broad spectrum of applications shall be established particularly with regard 
to MoBiDiK. 
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Chapter 2 
2Materials and Methods 
2.1 Membrane 
Hollow fiber membranes made from polyethersulfone (Pentair, Enschede, Netherlands) were 
used with the smallest pore size on the inside, which is less prone to fouling. The nominal 
pore size on the inside was 0.2 µm, and the porosity was 40%. On the outside surface the pore 
size was of approximately 1 to 2 µm. The inner and outer diameters were 1.5 mm and 
2.35 mm, respectively. This membrane was selected based on prior membrane screening 
performed by Frederike Carstensen (AVT.CVT, RWTH Aachen University). Prior to each 
experiment the membrane was flushed with deionized water to remove preservatives. The 
integrity of the membrane was checked using pressurized air at 1.5 bar. 
 
2.2 Polymers 
The following polymers were analyzed in this study regarding their leaching behavior: 
Polyamide 12 (PA) (outer diameter 6 mm, inner diameter 4 mm, Art. No. 259.11 S, Riegler & 
Co. KG, Bad Urach, Germany), polyurethane tubing (PUR) (Art. No. 259.16 S, Riegler & Co. 
KG, Bad Urach, Germany), polypropylene pipette tips (PP) (Art. No. 0030 000.919, 
Eppendorf AG, Hamburg, Germany), polytetrafluoroethylene tubing (Teflon) (Art. No. TFL 
6X4 NATUR, Landefeld Druckluft und Hydraulik GmbH, Kassel, Germany), polyether ether 
ketone bloc (PEEK) (PPEK Natur, Horbach, Langerwehe, Germany) and polyamide 6.6 cable 
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tie (Nylon) (Art. No. 541665 – 62, Conrad Electronic SE, Hirschau, Germany) (Figure 2-1). 
Further a hollow fiber membrane made from polyethersulfone (PES) (Pentair, Enschede, 
Netherlands) was investigated regarding its leaching behavior. 
 
 
Figure 2-1: Analyzed polymers from left to right: Polyurethane tubing (PUR), 
polytetrafluoroethylene tubing (Teflon), polyether ether ketone bloc (PEEK), polypropylene 
pipette tips (PP), polyamide 6.6 cable tie (Nylon) and polyamide 12 tubing (PA). 
 
2.3 Cultures and Media 
2.3.1 Hansenula polymorpha pCoM11sc3625 
The yeast Hansenula polymorpha was used in this study for assay qualification as well as in 
reverse-flow diafiltration experiments. H. polymorpha pCoM11sc3625 is an engineered 
strain, which was kindly provided by PharmedArtis GmbH (Aachen, Germany) (Melmer et 
al., 2011). This strain constitutively secrets a single-chain antibody. H. polymorpha was 
stored as cryo stock solution at -80 °C. Experiments with H. polymorpha were conducted in 
Syn6 medium (Stöckmann et al., 2003).  All chemicals used were of analytical grade. 
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Syn 6 MES Medium for Hansenula polymorpha 
Main solution 960 mL 
 (NH4)2SO4 15.3 g L
-1
  
 KH2PO4 2.0 g L
-1
  
 KCl 6.6 g L
-1
  
 MgSO4 · 7H2O 6.0 g L
-1
  
 NaCl 0.7 g L
-1
  
 2-morpholinoethanesulfonic acid (MES) 27.3 g L
-1
  
 Glucose (autoclaved separately) or Glycerol 20 g L
-1
  
Calcium chloride stock solution (autoclaved) 10 mL 
 CaCl2· 2H2O 100 g L
-1
  
Microelements stock solution (sterile filtered) 10 mL 
 Titriplex III 6.65 g L
-1
  
 (NH4)2Fe(SO4)2 · 6H2O 6.65 g L
-1
  
 CuSO4 · 5H2O 0.55 g L
-1
  
 ZnSO4 · 7H2O 2 g L
-1
  
 MnSO4 · H2O 2.65 g L
-1
  
Vitamins stock solution (sterile filtered) 10 mL 
 Biotin  0.04 g L
-1
  
 dissolved in Isopropanol 5 mL  
 and deionized water 5 mL  
 Thiamine 13.35 g L
-1
  
 dissolved in deionized water 90 mL  
Trace elements stock solution (sterile filtered) 10 mL 
 NiSO4 · 6H2O 0.065 g L
-1
  
 CoCl2 · 6H2O 0.065 g L
-1
  
 H3BO3 0.065 g L
-1
  
 KI 0.065 g L
-1
  
 Na2MoO4 · 2H2O 0.065 g L
-1
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2.3.2 Eschericha coli BL21 
The bacterium Eschericha coli BL21 (DE3) piRhotHi-2-EcFbFP was kindly provided by 
T. Drepper (Institute of Molecular Enzyme Technology, Heinrich-Heine-University 
Düsseldorf) and investigated in polymer material qualification experiments and stored as cryo 
stock solution at -80 °C. 
The E. coli strain was cultivated in Wilms-MOPS medium at a pH value of 7.5 according to 
Scheidle et al. (2007). All chemicals used were of analytical grade. 
 
Wilms-Mops Medium for Eschericha coli 
Main solution 977 mL 
 (NH4)2SO4 7.0 g L
-1
  
 KH2PO4 3.0 g L
-1
  
 Na2SO4 2.0 g L
-1
  
 3-(N-morpholino)propanesulfonic acid (MOPS) 41.9 g L
-1
  
 Glucose (autoclaved separately) 20 g L
-1
  
Magnesium sulfate stock solution (autoclaved) 10 mL 
 MgSO4· 7H2O 50 g L
-1
  
Trace elements stock solution (sterile filtered) 1 mL 
 ZnSO4 · 7H2O 0.54 g L
-1
  
 CuSO4 · 5H2O 0.48 g L
-1
  
 MnSO4 · H2O 0.30 g L
-1
  
 CoCl2 · 6H2O 0.54 g L
-1
  
 FeCl3 · 6H2O 41.7 g L
-1
  
 CaCl2 · 2H2O 1.98 g L
-1
  
 Titriplex III 33.4 g L
-1
  
Thiamine stock solution (sterile filtered) 1 mL 
 Thiamine  10.0 g L
-1
  
Ampicillin stock solution (sterile filtered) 1 mL 
 Ampicillin sodium salt 100 g L
-1
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2.3.3 Ustilago maydis MB215 
Ustilago maydis MB215 was used in polymer material qualification experiments. This fungus 
was kindly provided by M. Bölker (Philipps-Universität Marburg) and stored as cryo stock 
solution at -80 °C. 
Experiments with the fungus U. maydis were conducted in a modified medium at a pH value 
of 6 according to Verduyn et al. (1992). All chemicals used were of analytical grade. 
 
Verdyn Medium for Ustilago mydis 
Main solution 979 mL 
 (NH4)2SO4 5.0 g L
-1
  
 KH2PO4 0.5 g L
-1
  
 2-morpholinoethanesulfonic acid (MES) 0.1 g L
-1
  
 Glucose (autoclaved separately) 50.0 g L
-1
  
Magnesium sulfate stock solution (autoclaved) 10 mL 
 MgSO4· 7H2O 20 g L
-1
  
Iron sulfate stock solution (autoclaved) 10 mL 
 FeSO4 · 7H2O 1 g L
-1
  
Trace elements stock solution (sterile filtered) 1 mL 
 ZnSO4 · 7H2O 4.5 g L
-1
  
 CuSO4 · 5H2O 0.30 g L
-1
  
 MnCl2 · 2H2O 0.84 g L
-1
  
 CoCl2 · 6H2O 0.30 g L
-1
  
 Na2MoO4 · 2H2O 0.4 g L
-1
  
 CaCl2 · 2H2O 4.5 g L
-1
  
 FeSO4 · 7H2O 3 g L
-1
  
 H3BO3 1.0 g L
-1
  
 KI 0.1 g L
-1
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2.3.4 CHO DG44 
In this study the mammalian cell line CHO DG44 producing the human IgG antibody H10 
was used (Peuscher et al., 2014). This cell line was kindly provided by Fraunhofer Institute 
for Molecular Biology and Applied Ecology (IME, Aachen, Germany).  
Twice weekly the CHO-DG44 cells were passaged 1:20 in commercially available 
PowerCHO 2 medium (Lonza Group Ltd, Basel, Switzerland) supplemented with 4 mM       
L-glutamine (Life Technologies, Darmstadt, Germany). Cultures were incubated in 50 mL 
disposable bioreactors (TPP, Trasadingen, Switzerland) with a working volume of 10 mL at 
180 rpm, 37 °C, 5% CO2 in a Kühner ISF1-C-CO2 incubator (Kühner AG, Basel, 
Switzerland). 
 
2.4 Culture Conditions 
2.4.1 Pre-cultures 
Pre-cultures of the microbial cells, namely H. polymorpha, E. coli and U. maydis were 
cultivated in the respective medium according to Table 2-1. Every pre-culture was inoculated 
with 0.5 mL cryo stock solution per flask and harvested during its exponential growth phase.  
CHO DG44 pre-cultures used for inoculation of the perfusion bioreactor were cultivated in 
PowerCHO 2 medium (Lonza Group Ltd, Basel, Switzerland) supplemented with 4 mM       
L-glutamine (Life Technologies, Darmstadt, Germany). Cultures were incubated in disposable 
500 mL Erlenmeyer shake flasks (Sigma Aldrich Chemie GmbH, Steinheim, Germany) with a 
working volume of 100 mL at 180 rpm, 37 °C, 5% CO2 in a Kühner ISF1-C-CO2 incubator  
(Kühner AG, Basel, Switzerland). Typically cell densities of 1∙106 cells mL-1 were reached. 
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Table 2-1: Culture conditions of the various applied microbial culture strains 
Culture parameters E. coli BL21 U. maydis MB215 
H. polymorpha 
pCoM11sc3625 
Temperature 37 °C 30 °C 37 °C 
Shaking diameter 50 mm 50 mm 50 mm 
Shaking frequency 350 rpm 350 rpm 350 rpm 
Filling volume 12.5 mL 20 mL 12.5 mL 
 
 
2.4.2 RAMOS Experiments 
Cultures conducted in shake flasks were monitored online via the Respiration Activity 
MOnitoring System (RAMOS). This device measures the Oxygen Transfer Rate (OTR) and 
the Carbon dioxide Transfer Rate (CTR) of eight shake flasks simultaneously. The respiration 
Quotient (RQ) is calculated from these values. The OTR is a commonly used parameter to 
characterize aerobic cultures, as it reflects all oxygen converting metabolic activities such as 
microbial growth (Anderlei and Büchs, 2001; Anderlei et al., 2004).  
The material qualification assay was conducted in shakes flasks. Main cultures in these 
experiments were inoculated at OD600 = 0.1 (Spectrophotometer Genesys 20, Thermo Fisher 
Scientific, Bonn, Germany) if not stated otherwise. For offline analysis, main cultures were 
conducted in parallel in conventional 250 mL Erlenmeyer flasks under identical culture 
conditions.   
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2.4.3 Biocompatibility test for CHO cells 
A biocompatibility test was carried out by addition of the testing material (membrane and 
tubing) to a CHO DG44 culture conducted in T75 cell culture flasks  (Sigma Aldrich, 
St. Louis, MO, USA) filled with 20 mL supplemented Power CHO 2 medium. The T75 cell 
culture flasks were incubated at 37 °C and 5% CO2 in a Kühner ISF1-C-CO2 incubator for 
96 h without shaking. Viable cell densities of cultures in presence and absence of testing 
material were compared. The testing material had been sterilized by autoclaving prior to 
examination.  
 
2.4.4 Bioreactor Experiments with Yeast Cells 
Pre-cultures of H. polymorpha were cultivated in MES-buffered Syn6 medium in 250 mL 
RAMOS flasks filled with 10 mL. Cultures were incubated at 37 °C on a shaker set to 
350 rpm and a shaking diameter of 50 mm. All pre-cultures were harvested during the 
exponential growth phase.  
Continuous H. polymorpha cultures were grown in a 3 L fermenter (Applikon Biotechnology, 
Schiedam, Netherlands) filled with 1.5 L. All cultures were performed in Syn6 medium at 
37 °C without buffer. The pH value was adjusted to 5.5 with 5 M NaOH. To maintain a 
dissolved oxygen tension above 30% air saturation, the stirring and aeration rates were 
adjusted in the range of 500 – 1800 rpm and 1.5 – 4.5 L min-1, respectively as specified in the 
graphs if not stated otherwise. To prevent foam formation, Plurofac LF1200 (BASF, 
Ludwigshafen, Germany) was used as necessary. 
In continuous cultures without cell retention, the dilution rate (D) was increased 
(Equation 2.1) with an acceleration rate (a) of 0.001 h
-2
, based on the acceleration-stat mode 
described by Paalme et al. (1995) until the wash out point (Dmax). The initial dilution rate (D0) 
was set to 0.08 h
-1
: 
D = D0 + a∙t             (2.1) 
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In experiments with H. polymorpha and cell retention, D was raised in a stepwise fashion. To 
achieve stable conditions, each dilution rate was kept constant for five retention times. 
 
2.4.5 Bioreactor Experiments with CHO cells 
Batch cultures were conducted in a 3 L bioreactor (Applikon Biotechnology, Schiedam, 
Netherlands) filled with 1 L supplemented PowerCHO 2 medium at 37 °C. A marine impeller 
with a diameter of 60 mm stirred at 125 rpm. The pH was adjusted to 6.8 with autoclaved 
0.2 M NaOH. The set point of the dissolved oxygen tension (DOT) was 40% and maintained 
by pulsed aeration. The bioreactor was inoculated with a cell density of 1∙105 cells mL-1. 
Perfusion cultures were started in batch mode until a viable cell density of 1.8∙106 cells mL-1 
was reached applying the same settings. The bioreactor was equipped with a membrane 
module necessary for reverse-flow diafiltration (RFD). Dilution rates of D = 0.5 d
-1
, 1 d
-1
 and 
2 d
-1
 were investigated. 
 
2.5 Treatment of Single-use Polymers in Aqueous Culture 
Media 
Leaching of polymer additives was analyzed mainly for black polymer tubes consisting of 
Polyamide 12 (PA) (outer diameter 6 mm, inner diameter 4 mm, Art. No. 259.11 S, Riegler & 
Co. KG, Bad Urach, Germany) in aqueous culture media. A quantity of 4 g tubing equal to a 
length of 250 mm and a surface area of 7854 mm² was cut in pieces of 50 mm length and 
added to 100 mL of the respective basic medium (40 g L
-1
 PA). The tubing was heat sterilized 
in the medium at 121 °C and 1 bar overpressure for 20 min and removed afterwards. In order 
to attain set concentrations of PA, the medium, heat sterilized with tubing, was afterwards 
diluted with defined volumes of standard basic medium as stated in the particular 
experiments.  
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2.6 Analytics 
2.6.1 Protein Quantification 
The concentration of the human IgG antibody H10 was determined by means of Biacore 2000 
instrument equipped with a CM5-rg sensor chip (both GE Healthcare, Uppsala, Sweden) 
coupled with recombinant protein A. HBS-EP served as running buffer; 575 µg mL
-1
 H10 
antibody was used as standard.  
An assay for the determination of the single-chain antibody produced by Hansenula 
polymorpha is not established so far. Thus, two different methods, namely the bicinochoninic 
acid (BCA) Protein Assay and the Fast Protein Liquid Chromatography (FPLC) were 
investigated in this thesis. 
The bicinochoninic acid (BCA) Protein Assay determines protein concentrations by means of 
color changing regencies. In this study the Pierce BCA Protein Assay kit (Thermo Scientific, 
Rockford, USA) was used. Samples were analyzed regarding the microtiter procedure. Bovine 
Serum albumin (BSA) standards of 0.125 g L
-1
, 0.25 g L
-1
, 0.5 g L
-1
, 0.75 g L
-1
, 1 g L
-1
, 
1.5 g L
-1
 and 2 g L
-1
 were used for calibration. Supernatant of a H. polymorpha broth was 
analyzed with the BCA Protein Assay kit for validation. The same sample was analyzed 
without dilution and dilutions of 1:1, 1:2 and 1:10 for validation. 
Fast Protein Liquid Chromatography (FPLC) is a method to analyze and purify proteins. In 
this study, determination of proteins through size exclusion is investigated. An Äkta FPLC 
equipped with a HiPrep 26/10 Desalting column (both GE Healthcare Life Science, 
Buckinghamshire, UK) was used. A 0.1 M MES buffer served as running buffer. UV peaks 
measured by Monitor UPC 900 (also GE Healthcare) indicate the product concentration. 
Calibration were conducted five-fold with 3 mL BSA samples of 0.125 g L
-1
, 0.25 g L
-1
, 
0.5 g L
-1
, 0.75 g L
-1
, 1 g L
-1
 and 1.5 g L
-1
. Supernatant of a H. polymorpha broth was analyzed 
with FPLC for validation. The same sample was analyzed without dilution and dilutions of 
1:1, 1:2 and 1:10 for validation. 
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Fractions obtained by FPLC were analyzed by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-Page). Thus, the size of the protein is determined causing the peak in 
the FPLC signal. A volume of 6 µL of 550 µL NuPage
®
 Sample Buffer (Life Technologies, 
New York, USA) prepared with 50 µL DTT (Sigma Aldrich, St. Louis, USA) was mixed with 
18 µL sample volume and incubated for 5 min at 95 °C. Prefabricated NuPage
® 
Novex
®
         
4-12%
 
Bis-Tris gels (Life Technologies, New York, USA) were loaded with 7 µL Roti
®
 Mark 
Standard (Carl Roth, Karlsruhe, Germany) and 20 µL of each incubated sample. Gels were 
installed in a SDS chamber filled with 40 mL NuPage
®
 MES Running Buffer (Life 
Technologies, New York, USA) and 760 mL deionized water. Power was applied with the 
following settings for 50 min: 200 V, 120 mA and 25 W. Gels were stained afterwards for 
15 h with Roti
®
 Blue (Carl Roth, Karlsruhe, Germany), washed with a mixture of 25 mL 
methanol and 75 mL deionized water and photographed (Biorad, Hercules, USA).  
Antibodies were further analyzed by a reduced western blot (Holland et al., 2010). A 4-12% 
Bis-Tris NuPage gel (Carlsbad, CA, USA) was loaded with 30 µL sample volumes, 8 µL pre-
stained marker (Fermentas, Bulingston, ON, USA) and 6 µL of antibody standard if available. 
The gel was run for 45 min at 200 V in MES running buffer and afterwards transferred to a 
nitrocellulose membrane at 250 mA for 60 min. The membrane was blocked with 5% skim 
milk for 1 h at room temperature, washed with PBST, incubated in 15 mL PBS supplemented 
with 6 µL AP-conjugate goat anti-human antibodies (Sigma Aldrich, ST. Louis, MO, USA) 
for 1 h at room temperature and washed again with PBST.   
 
2.6.2 Viable Cell Density and Biomass Determination 
To quantify biomass of yeast, fungi and bacteria dry cell weight (DCW) was determined four-
fold. Eppendorf-tubes were stored at 80 °C for 24 hours, cooled in an exsiccator and weighed 
(SBC 31, Scaltec, Göttingen, Germany). The prepared Eppendorf-tubes were filled with 2 mL 
culture broth and centrifuged at 14000 rpm for 10 min (Centrifuge 1 - 15, Sigma Centrifuge 
GmbH, Göttingen, Germany). The supernatant was discarded. The pellet was stored at 80 °C 
for 60 hours, cooled and weighed. The difference in weight of the filled and unfilled 
Eppendorf-tube divided by the 2 mL broth equals the DCW.   
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Cell counting of viable CHO cells was conducted three-fold by using CASI I TT (Roche 
Inovartis, Basel, Switzerland).  
Various assays exist to determine the concentration of viable yeast cells. Within this thesis 
three assays were investigated and compared regarding their suitability for Hansenula 
polymorpha, namely the hemocytometer, the methylene blue assay and the LIVE/DEAD
®
 
FungaLight
TM
 Yeast Viability Kit analyzed by flow cytometry. 
A disposable hemocytometer (C-Chip; NI Neubauer Improved DHC-NO1; Montreal Biotech 
Inc., Dorval, PQ, Canada) was used to analyze the viability of yeasts in a suspension with a 
volume of 10 µL. By counting the number of cells in an optional number of squares marked 
on the Neubauer chamber, the concentration of cells can be extrapolated (Bastidas, 2013). 
Methylene blue (Sigma-Aldrich, St. Louis, MO, USA) was added to the suspension in a 1:20 
dilution. Since the dye diffuses mainly through the ruptured membrane of a dead cells, vivid  
and dead cells can easily be distinguished by their color (Schrek, 1963). Cell concentrations 
were determined by counting 5 of 25 small squares of a center square with a microscope at 
40-fold magnification. 
The methylene blue assay can also be used for the determination of viable cells. Methylene 
blue is a dye, which diffuses through the ruptured membranes of dead cells. According to 
Borzani and Vairo (1958) the diffusion can be regarded as a quantitative adsorption. 
Therefore, it can be described by the Freundlich law (Equation 2.2). This equation takes the 
mass of absorbed substance (mX), the mass of absorbing mass (mM), the equilibrium 
concentration of the solution (cS) and two constants (n and k) into account. 
𝑚𝑋
𝑚𝑀
  =   𝑘 ∙ 𝑐𝑆
𝑛            (2.2) 
The mass of absorbed substance (mX) equals the initial methylene blue concentration (cS,i) 
minus the equilibrium dye concentration (cS,f). The mass of absorbing mass (mM) is the 
concentration of dead cells as methylene blue diffuses mainly through the ruptured membrane 
of those cells. The concentration of dead cells equals the total yeast cell concentration (X) 
multiplied by the percentage of dead yeast cells (PX). Conversion of equation 2.2 leads to: 
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 𝐶𝑆,𝑖  −  𝐶𝑆,𝑓
𝐶𝑆,𝑓
𝑛   =   𝑘 ∙ 𝑃𝑋 ∙ 𝑋          (2.3) 
The concentration of methylene blue can be measured spectrophotometrically at 440 nm. 
With set dead cell concentrations, the constants k and n can be determined experimentally. 
With these values the unknown dead cell concentration (PX·X) could be determined using 
equation 2.3. If the individual values of PX and X are of interest, a sample can be split into two 
portions, one in which the cells are killed and one untreated.  As all cells are dead in the first 
portion (PX = 1), the total cell concentration can be determined. Hence, the percentage of dead 
cells in the untreated sample can be calculated out of the second portion (Borzani and Vairo, 
1958).   
Prior to application of this method, a calibration between the methylene blue concentration 
and the spectrophotometrically measured value has to be conducted. Here, a serial dilution of 
methylene blue in the medium was used with the following concentrations: 0.05 g L
-1
,  
0.067 g L
-1
, 0.083 g L
-1
, 0.100 g L
-1
, 0.125 g L
-1
, 0.143 g L
-1
, 0.167 g L
-1
,                  
0.200 g L
-1
 and 0.250 g L
-1
. 
The initial methylene blue concentration (cS,i) was set to 0.15 g L
-1
. Samples with dye added 
were incubated for 15 min at 1000 shakes min
-1
. Afterwards, the samples werecentrifuged at 
14000 rpm for 5 min (Sigma, Osterode am Harz, Germany). The equilibrium dye 
concentration (cS,f) was spectrophotometrically determined in the supernatant. 
To verify this method, yeast cell suspension of Hansenula polymorpha with final dead cell 
concentrations of 1.25 g L
-1
, 2.5 g L
-1
, 5 g L
-1
, 10 g L
-1
, 15 g L
-1
, 20 g L
-1
, 25 g L
-1
, 30 g L
-1
, 
40 g L
-1
, 50 g L
-1 
were prepared and analyzed. Furthermore, dead and vivid yeast cells were 
mixed in various ratios between 0 – 100% with a total yeast concentration of 30 g L-1. The 
concentration of dead cells was examined with the methylene blue assay. Hence, the influence 
of vivid cells on the equilibrium dye concentration could be determined as also vivid cells 
adsorb methylene blue to some extent.  
Flow cytometry enables the determination of physiological and physical state of single cells in 
high throughput by laser measurement (Endo et al., 1998). Among other features, fluorescent 
dye labels can be determined (Deere et al., 1998). In this study, the LIVE/DEAD
®
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FungaLight
TM
 Yeast Viability Kit (Molecular Probes
®
, Life Technologies, Germany) was 
used to determine the vivid and dead yeast cell concentrations. Staining was conducted by two 
fluorescence dyes, namely SYTO
®
 9 (Ex480/Em500 nm) and Propidiumiodid 
(Ex490/Em635 nm). Whereas SYTO
®
 9 stains all yeasts cells, Propidiumiodid stains only 
cells with compromised membranes. First, 500 µL of a yeast cell suspension was centrifuged 
at 14.000 rpm for 2 min (Sigma, Germany). The supernatant was discarded, while the pellet 
was washed with filtered (0.2 µm Filter) 0.9% NaCl. The pellet was centrifuged and 
resuspended in 500 µL 0.9% NaCl another time. Dilutions of cells with NaCl were prepared 
to obtain final cell concentrations between 50 to 500 cells µL
-1
. Staining with SYTO
®
 9 as 
well as SYTO
®
 9 and Propidiumiodid were performed. Therefore, 1 mL of the yeast cell 
dilution was incubated with 1 µL of the respective dye for 15 min to the exclusion of light 
before analysis. The following settings were used: Threshold parameter: FSC; Threshold: 2; 
FSC gain: x 8; Compensation: SSC 557 V, GRN 725 V, YLW 504 V, RED 682 V; Scale: 
Area 500, Width 500; Flow rate: medium (0.59 µL s
-1
); Events acquired in gate: 1000. 
Validation of the LIVE/DEAD
®
 FungaLight
TM
 Yeast Viability Kit (Molecular Probes) were 
conducted with dead yeast cells and known mixtures of dead and vivid yeast cells at various 
ratios of 0 – 100% dead cells.  
Cell viability was measured in chapter 5 and 7 by flow cytometry (Guava EasyCyte Mini 
Flow Cytometer System; Millipore, Billerica, MA, USA) and a LIVE/DEAD® 
FungaLightTM Yeast Viability Kit (Life Technologies, Carlsbad, CA, USA). To determine 
the number of vivid cells possibly passing through the membrane, permeate was also plated 
on YPG agar (Sigma-Aldrich, St. Louis, USA). All plates were incubated at 37 °C for 48 h.  
 
2.6.3 Preparation of Dead Yeast Cell Concentrations 
Cell death was either achieved by treatment with heat, Isopropanol or by starvation. Plating of 
treated cells on YPG agar was performed to prove cell death.  
Yeast cells were cultured in the RAMOS device according to chapter 2.4 until an OTR of 
20 mmol L
-1
 h
-1
 was reached. The suspension was centrifuged at 4000 rpm for 10 min 
(Centrifuge obtained from Hettich, Germany). Pellets were resuspended in 1.5 mL of 
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0.9% NaCl if heat treatment or 40% Isopropanol was applied and incubated for 15 min at 
95 °C or at room temperature, respectively. Afterwards cells were centrifuged at 14000 rpm 
for 3 min in a microcentrifuge (Sigma, Germany). While the supernatant was discarded, the 
pellet washed with 0.9% NaCl and centrifuged again for 5 min. Dry cell weight was 
determined and cells were resuspended in 0.9% NaCl to the desired concentrations.  
Batch cultures for starvation experiments were performed in a bioreactor and in the RAMOS 
device. Several samples at distinct time points were taken for offline analysis including: flow 
cytometry, plating on YPG agar, determination of DCW, Coulter Counter analysis and HPLC 
measurements of glucose and ethanol concentrations. The OTR was determined online in both 
devices, the bioreactor and the RAMOS device. Permittivity was measured only in the 
bioreactor. Starvation experiments last at least 72 h after the OTR drop due to depletion of 
glucose. Starved cells were harvested and centrifuged at 4000 rpm for 10 min (Hettich, 
Germany). Cell pellets were resuspended in 0.9% NaCl and centrifuged again.  
 
Table 2-2: Overview of dead cell preparation methods and examined assays 
Method 
Preparation method of dead cells 
Heat Isopropanol Starvation 
Hemocytometer + - - 
Methylene Blue Assay + + + 
Flow cytometry + + + 
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Dilutions of the treated yeast suspension with sterile 0.9% NaCl were plated on YPG agar. 
After 48 hours of incubation at 37 °C, colony forming units (CFUs) were counted and vivid 
cell concentrations in the original culture were calculated. An overview of the dead cell 
preparation methods and the examined assays are given in Table 2-2.  
 
2.6.4 Metabolites 
Glucose, ethanol, acetate and lactate concentrations were measured offline using HPLC 
(Dionex, Sunnyvale, USA) equipped with an Organic Acid-Resin HPLC separation column 
250 × 8 mm (CS-Chromatographie, Langerwehe, Germany) and a Shodex RI-71 detector 
(Techlab, Erkerode, Germany). Glutamine was determined by reverse phase HPLC 
(Shimadzu, Kyoto, Japan) using a Nucleodur c18 ec column (Macherey-Nagel, Düren, 
Germany). Ammonium concentration was determined by an ammonium test kit (Lot.: 
HC384800) in a Spectroquant Nova 60 (both Merck Millipore, Darmstadt, Germany) 
 
2.6.5 Exhaust Gas Analysis 
Exhaust gas was analyzed online regarding its oxygen and carbon dioxide concentration by an 
exhaust gas analyzer (Emerson XStream; Emerson, Weßling, Germany). Out of these values 
the oxygen transfer rate (OTR) and the respiratory quotient (RQ) were calculated according to 
Regestein et al. (2013). The OTR is commonly used to characterize aerobic cultures, as it 
describes oxygen consumption through metabolic activities, such as microbial growth or 
product formation (Anderlei and Büchs, 2001). The RQ provides information about the 
metabolism. RQ values close to 1.0 indicate oxidative growth on glucose, values above 1.0 
imply the formation of overflow metabolites such as ethanol (Anderlei et al., 2004). 
 
2.6.6 Gas Chromatography-Mass Spectrometry 
A 100 mL sample volume of medium, prepared as described in chapter 2.5 for H. polymorpha 
medium and heat sterilized with PA, was extracted with 100 mL ethyl acetate (Duffield et al., 
1994). In order to accelerate the extraction, the aqueous sample and the organic solvent were 
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mixed with a magnetic stir bar for 0.5 h. Subsequently, a separating funnel was used to 
partition the two phases. The organic phase was further dehydrated with sodium sulfate. After 
the solid phase was removed, the organic supernatant was analyzed by means of gas 
chromatography–mass spectrometry (GC-MS) (HP 5890 SERIES II Gas Chromatograph, 
Hewlett Packard, California, USA). According to GC-MS database, the respective additive 
was identified and its concentration was determined by applying a standard. 
To avoid cross contamination all applied jars, flasks and pipets consist of glass and were 
washed with pure grade ethyl acetate beforehand.  
 
2.7 Membrane Bioreactor for Reverse-flow Diafiltration 
Reverse-flow diafiltration (RFD) was first basically described by Carstensen et al. (2012b). 
RFD is a membrane based in situ cell retention and product recovery process. Permeate 
withdrawal and medium supply is alternated over the same submerged hollow-fiber 
membrane, minimizing the fouling layer. Different membrane bioreactor set-ups were 
analyzed and enhanced (Carstensen et al., 2013; Meier et al., 2014). The basis set-up is 
depicted schematically in Figure 2-2. One membrane is coiled around baffles and fixed by 
attached hooks. One end of the membrane is connected to the feed tubing, the other to the 
permeate tubing. Pressure sensors in the feed and permeate tubing measure the 
transmembrane pressure. Volume flows are calculated by balances of the feed and permeate 
tank. The reactor balance controls the non-filtered product stream pump. The applied RFD 
process in lab scale can be seen in Figure 2-3. The membranes coiled around the baffles are 
shown in Figure 2-3 A & B. Figure 2-3 C depicts the reactor with periphery, submerged 
membrane and culture broth, the permeate pump, the cell free permeate and the permeate 
balance.   
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Figure 2-2: Schematic drawing of reverse-flow diafiltratoin with one submerged hollow-fiber 
membrane. Continuous lines represent liquid flow, dashed-dotted and dotted lines indicate 
control and data record, respectively. D = Dilution rate [h
-1
], VL = Liquid volume [L], NF = 
Non-filtered ratio [-]. 
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Figure 2-3: Application of reverse-flow diafiltration. A) Hollow-fiber membrane wound 
spirally baffels with attached hooks B) Membrane submerged in medium C) RFD applied in a 
culture of Hansenula polymorpha pCoM11sc3625. Membrane is submerged in the reactor, 
permeate pump extracts cell-free permeate. 
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As shown in Figure 2-4, RFD consists of four steps: A) Permeate step: Permeate is withdrawn 
from the reactor (Feed pump stops, Permeate pump works), B) Flushing step: Permeate in the 
membrane is replaced by medium and flushed towards the permeate tank (both pumps work), 
C) Feeding step: Medium is pumped into the reactor (Feed pump works, Permeate pump 
stops), and D) Emptying step: Medium in the membrane is replaced with permeate (both 
pumps work in reverse direction). Arrows in Figure 2-4 indicate the intensity gradient of the 
flux due to pressure loss over the membrane length. In membrane terminology, flux refers to 
the specific flow rate given in L m
-2
 h
-1
. 
 
 
Figure 2-4: Steps of reverse-flow diafiltration: A) Permeate step, B) Flushing step, C) Feed 
step, D) Emptying step. X indicates a stop of the pump, → shows the direction of the flow. 
The arrow size indicates the intensity of the flux. A white filling represents fresh medium, a 
grey filling illustrates permeate of the culture broth. F is the flux generated by the pumps, the 
indices stand for the pump und the step, respectively. AM is the outer membrane area.  
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Figure 2-5 illustrates a true to scale representation of the sequential operation of RFD using 
time dependent mass flows in and out of the bioreactor for three membranes operated in 
parallel. In addition, the non-filtered product stream is shown (Figure 2-5, dashed-dotted line), 
which is operated continuously due to the slow control of the bioreactor balance. 
 
 
Figure 2-5: True to scale representation of the time dependent liquid flow in (positive values) 
and out (negative values) of the reactor in the reverse-flow diafiltration mode when 
membranes are operated in parallel with 50% cell retention. It should be noted that the 
volume pumped into (Feed) and out of the reactor (Emptying, permeate and non-filtered 
product stream) equals zero in every cycle.  
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2.7.1 Application of Yeast Cells 
 
 
Figure 2-6: Schematic diagram of the reverse-flow diafiltration with three microfiltration 
hollow fiber membranes (nominal pore size = 0.2 µm) operating in parallel.Two pressure 
sensors in the feed and permeate tank monitor the transmembrane pressure for one membrane 
as a representative for all three membranes. Bioreactor scale controls the non-filtered product 
stream pump. One experiment was carried out without membranes (dashed-dotted and dotted 
line), in one experiment the permeate was directed back into the fermenter (continuous and 
dashed-dotted-dotted line). All other experiments were carried out with membranes 
(continuous and dotted line). D = Dilution rate [h
-1
], VL = Liquid volume [L], NF = Non-
filtered ratio [-].The non-filtered product stream pump is controlled by the reactor weight 
(dashed line). 
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In experiments with H. polymorpha the reverse-flow diafiltration set-up was modified to 
allow operation of three membranes in parallel (pumps work simultaneously) or serial (pumps 
work in a time shifted sequence) as shown in Figure 2-6. Membranes operating in parallel and 
serial are referred to as conventional RFD and quasi-continuous RFD, respectively. Each 
membrane had a length of 1 m and was coiled around the baffles, where fixing hooks were 
attached. The ends of each membrane were individually attached to the tube system, one end 
to the feed tube, the other to the permeate tube. Peristaltic pumps were used to achieve an 
independent operation of each membrane. The non-filtered product stream (dashed line) 
removed cell debris among other. Its pump was regulated by a balance measuring the weight 
of the filled reactor (P-gain: 2000, Clycle-time: 1s). All integrated parts were tested regarding 
their biocompatibility before application (Meier et al., 2013).  
 
Table 2-3: Flux generated by feed pump and permeate pump depending on the dilution rate 
for conventional RFD: Three MF02 membranes with 1 m length each, NF = 0.5, aE = 1.69, 
aF = 0.7, tC = 510 s and VL = 1.5 L 
Step 
Step 
Times [s] 
Pump  
Flux [L m
-2
 h
-1
] 
for dilution rates [h
-1
] 
0.1 0.2 0.3 0.4 0.5 0.6 0.65 
Feed 150 
Feed (FF,Feed) 32.6 55.7 78.7 101.0 124.8 147.8 159.3 
Permeate (FP,Feed) 0 0 0 0 0 0 0 
Emptying 40 
Feed (FF,E) -50 -50 -50 -50 -50 -50 -50 
Permeate (FP,E) -10 -10 -10 -10 -10 -10 -10 
Permeate 300 
Feed (FF,P) 0 0 0 0 0 0 0 
Permeate (FP,P) 5.1 10.9 16.6 22.4 28.1 33.9 36.8 
Flushing 20 
Feed (FF,F) 30 30 30 30 30 30 30 
Permeate (FP,F) 30 30 30 30 30 30 30 
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Pressure values in one feed and permeate tube were continuously monitored as representative 
values for all three membranes by pressure sensors (WIKA Alexander Wiegand SE & Co. 
KG, Klingenberg, Germany) with a measuring range from 0 to 2.5 bar absolute. Flux of feed 
and permeate was calculated based on data from the two associated balances.  
Cell retention experiments were carried out in conventional RFD if not stated otherwise. To 
examine the impact of the membrane and RFD on cell viability and product yield, an 
experiment was carried out in which permeate was directly pumped back into the reactor 
(Figure 2-6, dashed-dotted-dotted line). Consequently, the non-filtered flow rate equaled the 
feed flux, which was similar to a conventional continuous culture. One experiment was 
conducted without membranes (Figure 2-6, dashed-dotted and dotted line), but with feeding 
times equivalent to the settings of conventional RFD (Table 2-3). 
 
Table 2-4: Flux generated by feed pump and permeate pump depending on the dilution rate 
for membranes operated in parallel: Three MF02 membranes with 1 m length each, NF = 0.5, 
aE = 1.69, aF = 0.7, tC = 540 s and VL = 1.5 L 
Step 
Step 
times [s] 
Pump 
Flux [L m
-2
 h
-1
] 
for dilution rates [h
-1
] 
0.1 0.2 
Feed 180 
Feed (FF,P) 32.6 55.7 
Permeate (FP,P) 0 0 
Emptying 40 
Feed (FF,F) -50 -50 
Permeate (FP,F) -10 -10 
Permeate 300 
Feed (FF,Feed) 0 0 
Permeate (FP,Feed) 5.1 10.9 
Flushing 20 
Feed (FF,E) 30 30 
Permeate (FP,E) 30  30 
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The calculations of the fluxes were developed in chapter 4 and summarized in Table 4-1. The 
values used for conventional RFD with a feed step time of 150 s and 180 s are given in Table 
2-3 and Table 2-4, respectively. Pump settings for the application of serial RFD are given in 
Table 2-5. Algebraic signs indicate the flow direction (compare Figure 2-4). It should be 
noted that fluxes in the feed and permeate step do not double for doubled dilution rates as the 
impact of the volume emptied (compare Figure 2-5) decreases with increasing dilution rate. 
Detailed information on the settings and design of RFD steps is given in chapter 4. 
 
 
Table 2-5: Flux generated by feed pump and permeate pump depending on the dilution rate 
and step for membranes operated serial.Conditions: Three MF02 membranes with 1 m length 
each, NF = 0.5, aE = 1.69, aF = 0.7, tC = 540 s and VL = 1.5 L 
Step 
Step 
Times [s] 
Pump  
Flux   [L m
-2
 h
-1
] 
for dilution rate [h
-1
] 
0.1 0.2 0.3 0.4 0.5 
Feed 180 
Feed (FF,P) 29.3 49.6 69.9 90.2 110.6 
Permeate (FP,P) 0 0 0 0 0 
Emptying 40 
Feed (FF,F) -50 -50 -50 -50 -50 
Permeate (FP,F) -10 -10 -10 -10 -10 
Permeate 300 
Feed (FF,Feed) 0 0 0 0 0 
Permeate (FP,Feed) 6.0 12.1 18.2 24.3 30.4 
Flushing 20 
Feed (FF,E) 30 30 30 30 30 
Permeate (FP,E) 30 30 30 30 30 
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2.7.2 Application of CHO DG44 cells 
A conventional RFD as shown in Figure 2-2 was applied for CHO DG44 cells. The 
membrane module was constructed as described by Carstensen et al. (2013; 2012b), but 
modified for an application with mammalian cell lines. One hollow fiber membrane with a 
length of 1 m was coiled around the sensors (pH and DOT) and the harvest tube. The ends of 
the membrane were attached to the feed and the permeate tube. Nine-tenth of the culture broth 
was gained filtered, one-tenth was pumped out non-filtered (NF = 0.1) to remove cell debris 
and excessive biomass. The non-filtered product stream was controlled by the bioreactor 
balance.  
 
Table 2-6: Flux generated by feed pump permeate pump depending on dilution rates for a 
perfusion culture applying reverse-flow diafiltration: One MF02 membrane with 1 m length 
each, NF = 0.1, aE = 1.69, aF = 0.7, tC = 510 s and VL = 1 L 
Step Step times [s] Pump  
Flux [L m
-2
 h
-1
] 
for dilution rate [d
-1
] 
0.5 1 2 
Feed 150 
Feed (FF,P) 20.4 29.9 49.1 
Permeate (FP,P) 0 0 0 
Emptying 40 
Feed (FF,F) -50.0 -50.0 -50.0 
Permeate (FP,F) -10.0 -10.0 -10.0 
Permeate 300 
Feed (FF,Feed) 0 0 0 
Permeate (FP,Feed) 4.2 8.6 18.2 
Flushing 20 
Feed (FF,E) 30.0 30.0 30.0 
Permeate (FP,E) 30.0 30.0 30.0 
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Pressure sensors in the feed and permeate tube monitored the transmembrane pressure 
continuously (WIKA Alexander Wiegand SE & Co. KG, Klingenberg, Germany) within a 
measuring range from 0 to 2.5 bar absolute. Fluxes in and out of the bioreactor were 
calculated based on data from a feed and a permeate balance.  
The applied fluxess in this study are given in Table 2-6 for dilution rates of D = 0.5 d
-1
, 1 d
-1
 
and 2 d
-1
. Positive and negative values indicate pumps running as shown in Figure 2-2 and in 
reverse direction, respectively. The ratios of volume flushed aF (flushing step) and volume 
emptied aE (emptying step) to the membrane volume were set to aF = 0.7 and aE = 1.69, 
respectively. Detailed information regarding the settings and design of RFD steps is given in 
chapter 4.  
 
2.8 Flux-step Experiments 
Membrane screening was performed to determine a suitable membrane for optimal cell 
retention and antibody recovery. Therefore, the flux-step method was applied (van der Marel 
et al., 2009). According to the flux-step method, a high flux phase alternates with a low flux 
phase. The flux during the high flux phase is increased stepwise, while the transmembrane 
pressure (TMP) is monitored. At low flux or the so-called relaxation phase, reversible fouling 
that occurs during the high flux phase is removed due to the conditions applied (e.g. generated 
by stirring). Each flux step, consisting of a high flux and low flux phase, yields a 
characteristic increase in TMP. The increase during high flux is referred to as "total TMP 
increase". The "irreversible TMP increase" is defined as the pressure difference before and 
after high flux (Figure 2-7). For stable long-term operations, the irreversible TMP increase 
must be subcritical to ensure only minimal fouling. The critical TMP increase depends on the 
membrane, the suspension as well as the process and has to be determined individually for 
every application. In this study, it was set to 45 Pa min
-1
 based on data obtained by Frederike 
Carstensen (AVT.CVT, RWTH Aachen University). Intersection of the irreversible TMP 
increase with the critical TMP increase determines the critical flux. 
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Figure 2-7: Exemplary irreversible and total TMP increase measured for a transmembrane 
flux of 30 L m
-2
 h
-1
. Alternating high flux (30 L m
-2
 h
-1
) and low flux (10 L m
-2
 h
-1
) yield in a 
characteristic increase of the TMP. Increase during high flux is revered to as “Total TMP 
increase”, increase of TMP before and after high flux is applied is revered to as “Irreversible 
TMP increase”.   
 
No backflushing was performed in flux step experiments with Hansenula polymorpha to 
simulate worst conditions regarding membrane fouling as settings of RFD were not fixed at 
that time. Since better conditions for the membrane are applied during RFD mode, the 
obtained data of the flux step experiments can be regarded as conservative. To a later point, 
experiments with CHO DG44 cells were conducted with backflushing conditions comparable 
to reverse-flow diafiltration as configuration of RFD was finalized by then. Hence, results are 
more accurate. 
The specific filtration area of RFD for the chosen membrane-CHO medium combination was 
calculated based on the critical flux and compared to data obtained by literature for other 
membrane based cell retention devices (Su, 1995; Voisard et al., 2003). 
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Chapter 3 
3Material and Assay Qualification 
Leaching of polymer materials can negatively influence cultivations of microorganism. As 
polymer materials were used in this thesis and no standardized biocompatibility test exists in 
literature, an analytical biocompatibility test for polymer materials is developed in the first 
part of this chapter. The breathing behavior of various microorganisms was determined by 
means of Respiration Activity MOnitoring Systems (RAMOS) as a function of the added 
amount of polymers commonly applied in biotechnology. This work is based on the thesis of 
Elena Herweg (2012) and was published in Meier et al. (2013). In the second part, an assay to 
determine the protein amount secreted by Hansenula polymorpha is established. Most of the 
results here were obtained by Sara Coelho (2012). Methods to determine the viable yeast cell 
concentration are investigated and validated in the last part of this chapter. Anne Worsch 
conducted the corresponding experiments (2013).   
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3.1 Quantifying the Release of Polymer Additives from 
Single-use Materials by Respiration Activity 
Monitoring 
3.1.1 Effect of Polyamide 12 Tubing on Yeast 
To investigate the effect of Polyamide 12 tubing (PA) on H. polymorpha, different 
concentrations of PA were added to the culture medium during heat sterilization. The 
metabolic behavior was determined via the RAMOS device. Figure 3-1 shows the online 
measured Oxygen Transfer Rates (OTR) as well as the offline measured Dry cell weights 
(DCW) and glucose concentrations.  
Compared to the reference medium without PA, the cultures with PA concentrations of       
0.4 – 4 g L-1 show no effect with regard to OTR, DCW and glucose concentration. All 
corresponding OTR curves reach a maximum of approx. 50 mmol L
-1
 h
-1
 after 20 h, the 
cultures have a DCW of 8 g L
-1
 and no glucose is left in the media. PA concentrations of      
10 – 20 g L-1 influence and decelerate the respiration activity and the growth of 
H. polymorpha, but do not inhibit it completely. The culture with a concentration of 10 g L
-1
 
PA reaches its maximal OTR value between 22 – 24 h. The maximal value of the OTR 
corresponding to a concentration of 20 g L
-1
 PA is not reached after 24 h. At that time, 
approximately 10 g L
-1
 glucose is left in the culture medium. For a PA concentration of 
40 g L
-1
, no growth can be detected, neither in the OTR nor in the DCW, nor in the glucose 
consumption, which remains at a constant level of 20 g L
-1
. 
Figure 3-1 demonstrates that a PA concentration of 10 g L
-1
 and above during heat 
sterilization influence the respiration activity of the yeast H. polymorpha considerably and can 
even inhibit its growth completely. PA concentrations of 4 g L
-1
 and below show no effect 
with regard to OTR, DCW and glucose concentration. Hence, a PA concentration between  
4 – 10 g L-1 represents a threshold concentration for the inhibition of the respiration activity 
including the growth of this yeast. An effect of PA concentrations barely above this threshold 
can clearly be monitored using the RAMOS device, though they are hardly detectable offline 
e.g. by DCW and glucose depletion measurements (Figure 3-1, 10 g L
-1
 PA). Thus, applying 
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the RAMOS device generates threshold data for particular applications, in contrast to tests 
cited in the literature (Jenke, 2007a). 
 
 
Figure 3-1: Effect of different concentrations of Polyamide 12 (PA) tubing (di = 4 mm, 
do = 6 mm, black) in the culture medium on the growth behavior and respiration activity of 
H. polymorpha pCoM11sc3625. Culture conditions: Synthetic Syn-6-MES medium, pH value 
of 6.0, T = 37 °C. The PA in the culture medium was heat sterilized (121 °C, 21 min) and 
removed before inoculation. The optical density of the culture after inoculation was 0.1. A) 
Oxygen transfer rate (OTR). B) Dry cell weight (DCW). C) Glucose concentration. 
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3.1.2 Effect of the Volume of Inoculum  
As it was proven before, the volume of inoculum influences the microbial growth behavior 
(Huber et al., 2010). Therefore, the impact of the volume of inoculum was investigated in a 
culture medium, which has been heat sterilized together with 20 g L
-1
 PA (Figure 3-2). In 
contrast to the first experiment, this culture was monitored for 72 h. With media, having an 
initial optical density of 0.1 after inoculation, a maximal OTR of 22 mmol L
-1
 h
-1
 is reached 
after 48 h. In comparison to media with an initial optical density of 0.1, those media with 
higher initial optical densities have shorter culture times and considerably higher OTRs. The 
medium with an initial optical density of 2.1 reaches a maximal OTR of 40 mmol L
-1
 h
-1
 after 
11 h of culture. Another additional peak is visible after the first peak in all cultures. These 
peaks indicate the consumption of overflow metabolites, formed in the first phase of the 
culture. This is a typical phenomenon found in Hansenula polymorpha cultures (Stöckmann et 
al., 2003). A similar OTR curve would have been detected in the corresponding culture in 
Figure 3-, if the culture time would have been longer. 
 
 
Figure 3-2: Effect of different volumes of inoculum on the respiration activity of 
H. polymorpha pCoM11sc3625 in synthetic Syn-6-MES medium, pH value of 6.0, T = 37 °C 
and 20 g polyamide per L medium. The Polyamide 12 tubing (di = 4 mm, do = 6 mm, black) 
was heat sterilized once in culture medium (121 °C, 21 min) and removed before inoculation. 
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In this experiment the inhibiting effect of PA could be reduced, even if the PA concentration 
is far above the threshold. If the volume of inoculum is increased, initial growth rates 
increases considerably, so the method is less sensitive (Figure 3-2). Consequently, a low 
initial optical density can result in an inhibition or even termination of metabolic activities, 
although no influence of polymer additives was observed at higher initial optical densities 
with offline data.  
 
3.1.3 Effect of Several Heat Sterilization Cycles  
To study, whether leaching of polymer additives occurs only during the first heat sterilization 
cycle, or appears multiple times, 40 g of the same tubing was heat sterilized in 1 L culture 
medium for one to five cycles at 121 °C for 20 min. For every sterilization cycle, fresh 
medium was used. Then, respiration activity curves were recorded for each of those culture 
media as well as for a reference medium without any PA. Figure 3-3 depicts the results. 
Whereas no respiration activity can be detected for one and two heat sterilization cycles, a 
slight increase in the oxygen transfer rate was measured for the culture medium with the PA 
heat sterilized for the 3
rd
 cycle. The respiration activity curves of each subsequent sterilization 
cycle increasingly resemble the microbial respiration activity of the reference culture. Culture 
medium with the PA heat sterilized for the 4
th
 and 5
th
 cycle have a maximal OTR of 
26 mmol L
-1
 h
-1
 reached after 36 h and 37 mmol L
-1
 h
-1
 reached after 28 h, respectively. In 
these two OTR curves two further peaks are visible after the first one, indicating the 
conversion of overflow metabolites.  
A GC-MS analysis of the culture media extracted with ethyl acetate revealed the presence of 
N-Butylbenzenesulfonamide (NBBS) in the sample. NBBS is a widely used plasticizer in 
polyacetals, polycarbonates, polysulfones, Nylon 11 and Nylon 12 and in flexible tubing 
(Rider et al., 2012; Skjevrak et al., 2005). NBBS is known to be toxic to human at 
concentrations above 3.7106 g L-1 if inhaled (National Toxicology Program, 2010). It belongs 
to the group of sulfonamides. Some members of this group serve as antibiotics, based on their 
nature as competitive inhibitors of the enzyme dihydropteroate synthetase (DHPS), which is 
active in folic acid synthesis (Fiege et al., 2000). Thus, the observed effect of decreasing 
inhibition at increasing initial biomass concentration may be explained by a decreasing ratio 
of NBBS to biomass or rather enzyme concentration (DHPS) (Figure 3-2). 
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Figure 3-3: Impact of repeated heat sterilization cycles of Polyamide 12 tubing (di = 4 mm, 
do = 6 mm, black) in culture medium on the respiration activity of H. polymorpha 
pCoM11sc3625. For multiple numbers of sterilizations, culture medium was refreshed after 
every sterilization cycle (121 °C, 21 min). Culture conditions: Synthetic Syn-6-MES medium, 
pH value of 6.0, T = 37 °C and 40 g polyamide per L medium. The optical density after 
inoculation was 0.1. 
 
The concentrations of NBBS were determined in the culture media after the aforementioned 
PA sterilization cycles. As shown in Figure 3-4, approx. 0.8 g L
-1
 is present in the medium 
containing 40 g L
-1
 PA that was heat sterilized for the first cycle. The concentration of NBBS 
declines in a non–linear fashion to approx. 0.52 g L-1 after the 5th sterilization cycle.  
To validate the GC-MS data, the determined concentrations of liquid NBBS were added to the 
culture medium, and, thus, respiration activity curves were measured. Figure 3-5 shows the 
respiration activity curves corresponding to the 1
st
, 4
th
 and 5
th
 sterilization cycle with a NBBS 
concentration of 0.8 g L
-1
, 0.55 g L
-1
 and 0.52 g L
-1
, respectively, as well as a reference 
respiration activity curve for the medium without any additional NBBS. Whereas no 
respiration activity is detectable in the medium with 0.8 g L
-1
 additional NBBS, those media 
having 0.52 g L
-1
 and 0.55 g L
-1
 NBBS show a longer lag-phase and a lower respiration 
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activity. They reach a maximal OTR of 41 mmol L
-1
 h
-1
 after 28 h and 25 mmol L
-1
 h
-1
 after 
approx. 44 h, respectively.  
   
 
Figure 3-4: Concentrations of N-Butylbenzenesulfonamide (NBBS) determined in the culture 
medium after repeated cycles of heat sterilization with 40 g per L Polyamide 12 tubing 
(di = 4 mm, do = 6 mm, black).  New Syn 6 culture medium was used after every sterilization 
cycle (121 °C, 21 min). 
 
A comparison of Figure 3-3 and Figure 3-5 shows a good agreement of the culture with 
NBBS added as pure compound and the culture with different PA concentrations. This proofs 
NBBS to be the direct cause of altered respiration activity of the microbial cultures. It appears 
to be processed in PA in large amounts, as even five sterilization cycles of PA are not 
sufficient to lower the leaching concentrations below the threshold (Figure 3-3). NBBS was 
also found to leach out from PA cooking utensils (Skjevrak et al., 2005). This fact is giving 
cause for concern, considering the effect of this plasticizer on microbial activity. 
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Figure 3-5: Effect of different concentrations of N-Butylbenzenesulfonamide on the 
respiration activity of H. polymorpha pCoM11sc3625.  Culture conditions: Synthetic Syn-6-
MES medium, buffered at pH value of 6.0, T = 37 °C. The optical density after inoculation 
was 0.1.  
 
The deviation in Figure 3-3 and Figure 3-5 regarding the maximal OTR value is      
± 4 mmol L
-1
 h
-1
, which is reached after ± 8 h. Hence, within the range of 4 – 20 g L-1 PA, 
changes in the NBBS-concentration can be accurately and reproducibly revealed by using the 
RAMOS device. In this range even small changes of 0.03 g L
-1
 NBBS have a clear and non-
linear impact on the culture (Figure 3-5, 0.52 and 0.55 g L
-1
 NBBS). Consequently, a 
determination of the concentration of a compound leaching out from a polymer by chemical 
analysis is insufficient without investigations of its effect on microbial growth and metabolic 
activity. 
  
3.1.4 Effect of Polyamide 12 Tubing on Bacteria and Fungi 
To demonstrate that PA affects microorganisms in general, the same concentrations of PA as 
in chapter 3.1.1 were studied on the bacterium E. coli as well as the fungus U. maydis. All 
respiration activity curves measured via the RAMOS device are illustrated in Figure 3-6. In 
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both cultures the organisms do not respire when they are subjected to PA in a concentration of 
40 g L
-1
 PA. Moreover, PA concentrations of 10 g L
-1
 and 20 g L
-1
 lead to a delayed 
respiration activity of E. coli as well as to a delayed or even terminated respiration activity of 
U. maydis.  
 
 
Figure 3-6: Effect of different concentrations of Polyamide 12 tubing (di = 4 mm, do = 6 mm, 
black) in the culture medium on the respiration activity of Escherichia coli BL21 (DE3) 
piRhotHi-2-EcFbFP and Ustilago maydis MB215. A) E. coli. Culture conditions: Synthetic 
Wilms-Mops medium, 12.5 mL filling volume, pH value of 7.5, T = 37 °C. The optical 
density after inoculation was 0.1. B) U. maydis. Culture conditions: Synthetic Verduyn 
medium, 20 mL filling volume, pH value of 6.0, T = 30 °C. The optical density after 
inoculation was 0.1. 
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Although PA affects E. coli and U. maydis differently (Figure 3-6), leaching of NBBS clearly 
influences also those microorganisms. Thus, materials intended for heat sterilized single-use 
culture systems and other biological applications should be tested for biocompatibility with 
the respective microorganism. A predication about the effect of polymer additives on 
microorganism based on the investigation of other microorganism is hardly possible (Cairns, 
1986). 
 
3.1.5 Effect of Various Polymers on Yeast 
As PA appears to be ill suited for applications in heat sterilized culture vessels, the following 
polymers were investigated regarding their biocompatibility as well: Polyether ether ketone 
bloc (PEEK), polytetrafluoroethylene tubing (Teflon), polypropylene pipette tips (PP), 
Polyurethane tubing (PUR), Polyamide 6.6 cable tie (Nylon) and polyethersulfone membrane 
(PES).  Figure 3-7 illustrates the microbial respiration activity curves with these polymers and 
PA as well as one reference curve of a culture without a polymer. PUR, PP, Teflon, PEEK 
and PES do not show an influence on the respiration activity curves, whereas Nylon extends 
the respiration activity lag-phase as observed for PA, though the effect on the metabolic 
activity for Nylon is smaller than for PA.  
GC-MS measurements of the sample containing Nylon revealed the UV stabilizer and 
antioxidant 2,6-Di-tert-butylphenol (2,6-DTBP) as well as the monomer                               
1,8-Diazacyclotetradecane-2,7-dione (1,8-DACTD-2,7-D). Whereas 2,6-DTBP has a low 
toxicity (Fiege et al., 2000), 1,8-DACTD-2,7-D is known to inhibit yeasts (NCI Yeast 
Anticancer Drug Screen) and thus, may cause the inhibiting effect of Nylon H. polymorpha. 
This chapter demonstrates the need to test polymers regarding their biocompatibility prior to 
application in bioreactors. Predication of leaching behavior and its influence on 
microorganisms is hardly possible. Thus, the here established biocompatibility test is used for 
all polymers applied in this study.    
 
 
Material and Assay Qualification  49 
  
 
 
Figure 3-7: Effect of different polymers heat sterilized in the culture medium on the 
respiration activity of Hansenula polymorpha pCoM11sc3625.  The polymers were removed 
after sterilization. The amount of polymer was 0.5 g per flask (40 g L
-1
 culture medium) each. 
Culture conditions: Synthetic Syn-6-MES medium, buffered at pH value of 6.0, T = 37 °C. 
The optical density after inoculation was 0.1.  
 
 
3.2 Establishment of a Protein Quantification Assay 
An assay to determine the concentration of the single-chain antibody secreted by 
H. polymorpha was not established before the beginning of this work. Thus, two assays were 
analyzed regarding their suitability within this chapter: Bicinchoninic Acid (BCA) Protein 
Assay, a standard method to determine protein concentration and Fast Protein Liquid 
Chromatography (FPLC), originally a device for purification of proteins.  
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3.2.1 Bicinchoninic Acid  (BCA) Protein Assay 
BCA Protein Assay was investigated regarding its ability to determine the single-chain 
antibody concentration in a sample of supernatant of H. polymorpha broth. The calibration 
with protein standards of BSA reveals good results with a coefficient of determination of 
0.976 (Figure 3-8, open diamonds). For validation one sample of H. polymorpha was diluted 
in various ratios and its absorption measured (closed triangles). Concentrations determined by 
correction of the measured values by the dilution factor (closed circles) should yield the same 
concentration as the same sample was analyzed. Thus, the closed circles should be on a 
vertical line, if the BCA Protein Assay is reliable. However, the determined concentrations of 
the same sample differ widely. The culture medium is composed of EDTA among other. 
EDTA is known to interfere with the BCA Protein Assay (Lottspeich and Zorbas, 1998) and, 
thus, may cause this deviation. As a conclusion, the BCA Protein Assay is considered as not 
suitable for analysis of the samples obtained in this study. 
 
 
Figure 3-8: Calibration of BCA Protein Assay with BSA standards and sample analysis. 
Linear trend line is determined by double measurement of BSA standard (open diamonds) 
with intersection at (0/0). The same sample was measured with different dilutions (closed 
triangles) and corrected by the dilution factor (closed circles). 
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3.2.2 Fast Protein Liquid Chromatography (FPLC) 
Fast protein liquid chromatography is a size exclusion method known for purification (Jager 
et al., 2011). Bigger molecules such as proteins result in a UV peak at the beginning of the 
purification procedure whereas small molecules elute latter. Thus, if the sample contains 
solely the target protein and smaller molecules such as salts, a distinct peak is visible for the 
protein. Hence, FPLC may be used to determine the peak area of the target protein, the single-
chain antibody.  
 
 
Figure 3-9: Determination of antibody concentration in supernatant of H. polymorpha 
pCoM11sc3625 broth using FPLC. Conditions: Synthetic Syn6 medium, 20 g L
-1
 Glycerol. 
A) UV signal. B) SDS Page of 15 µL sample volume (fractions obtained by FPLC), 8 µL 
Marker, M: marker, F: free, 1 – 14: number of fractions. 
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 The UV signal of one exemplary H. polymorpha sample measured by FPLC and the obtained 
fractions are depicted in Figure 3-9 A. The fractions are marked with vertical lines and 
numbers from 1 – 14.  A distinct peak is visible at an eluation volume of approximately 
12 mL (mainly fraction 3) and various overlapping peaks are detected in the range from        
25 – 60 mL eluation volume (fraction 6 – 12). All fractions obtained by FPLC of the 
exemplary sample were investigated by a western blot to verify the protein being in fraction 3 
and salts causing the peaks at higher eluation volumes. The corresponding western blot of the 
fractions (Figure 3-9 B) show a clear band in fraction 3 in the expected size range for the 
single-chain antibody. No bands were visible in other samples. Thus, the first distinct peak in 
the UV signal can be used for the calculation of the protein concentration.  
 
 
Figure 3-10: Calibration of FPLC Assay with BSA standards and sample analysis. Linear 
trend line and standard deviation was calculated out of five samples of BSA standard (open 
diamonds) with intersection at (0/0). The same sample was measured with different dilutions 
(closed triangles) and corrected by the dilution factor (closed circles). 
 
To verify reproducibility of the FPLC measurement a standard calibration was conducted with 
five samples each of six concentrations of BSA. For validation the same sample of 
H. polymorpha supernatant was measured diluted in various ratios. The result is depicted in 
Figure 3-10. The calibration via BSA (Figure 3-10, open diamonds) reveals a linear trend with 
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a coefficient of determination of 0.9871. The standard deviation of the five BSA samples is 
less than 5% for all samples. The corrected H. polymorpha samples are almost on a vertical 
line (Figure 3-10, closed circles), indicating that the sample is measured reproducibly 
independent of the dilution. Hence, the FPLC assay proved to be suitable for determination of 
the single-chain antibody used in this study and will be applied in this study. 
 
 
3.3 Determination of Yeast Cell Viability 
The viability of cells is of interest in every biotechnological process as in some cases higher 
product concentrations are yield under stress conditions, whereas other processes demand a 
high viability of cells. H. polymorpha secrets single-chain antibody to a greater extend if the 
viability of the culture is high. Thus, viability should be investigated for the special conditions 
of reverse-flow diafiltration in comparison to a conventional continuous culture without cell 
retention. Therefore, three different viability assays were investigated and compared with 
regard to their application for H. polymorpha.       
 
  
3.3.1 Hemocytometer 
Examination of vivid as well as heat treated H. polymorpha cells in a Neubauer improved 
chamber were conducted with a 40-fold magnification (Figure 3-11). All samples were 
stained with methylene blue. Cells were hard to detect at this magnification and no significant 
difference between vivid (Figure 3-11 A) and heat treated (Figure 3-11 B) cells could be 
determined. A clear image could not be obtained at 100-fold magnification. Thus, the 
hemocytometer method was considered as not suitable for the determination of viability of    
H. polymorpha. 
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Figure 3-11: Determination of dead cells in a Neubauer improved chamber. Samples of 
Hansenula polymorpha pCoM11sc3625 were stained with methylene blue in a dilution of 
1:20 and microscopically analyzed at a 40-fold magnification. A) Vivid cells. B) Heat treated 
cells (95 °C for 15 min). 
 
3.3.2 Methylene Blue Assay 
In the Methylene Blue Assay the concentration of dead cells in a sample was analyzed by 
measuring indirectly the amount of dye diffused into dead cells. Prior, a correlation of the 
spectrometric measured OD440 and the methylene blue concentration has to be determined. 
The two values correlate linear with a coefficient of determination of 0.985 as shown in 
Figure 3-12.  
After calibration the specific parameters k and n (Equation 2.2) have to be determined 
experimentally by measuring the methylene blue concentration for various concentrations of 
treated H. polymorpha cells. Heat treated cells as well as cells treated with isopropanol and 
starved cells (compare Table 2-2) were examined. Figure 3-13 depicts the measured data for 
all three treatment methods (dots) as well as the resulting fitted data (continuous line). 
Depending on the threatening method the resulting values for k and n vary from 0.05 – 0.09 
and 0.558 – 1.499, respectively. This range of values leads to a deviations of the dead cell 
concentration higher than the initial concentration. Thus, the parameters k and n cannot be 
determined with an accurateness necessary for resilient results with H. polymorpha. Thus, the 
methylene Blue Assay was not used in this study for the determination of the viability of H. 
polymorpha.     
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Figure 3-12: Correlation of methylene blue concentration and spectrometric measured OD440. 
A linear trend line is determined with an intersection at (0/0) and used for further calculations. 
 
 
Figure 3-13: Determination of parameters k and n for different treatment methods of 
Hansenula polymorpha pCoM11sc3625 broth.  Treatment with 40% of Isopropanol for 15 
min (black triangles), 95 °C applied for 15 min (grey circles) or starved cells (72 h without 
respiration activity, black diamonds). Data points represent measured values; continuous lines 
represent the modelled values. Initial dye concentration cS,i = 0.014 g L
-1
. 
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3.3.3 Flow Cytometry 
Determination of dead yeast cell concentrations was conducted with the LIVE/DEAD
®
 
FungaLight
TM
 Yeast Viability Kit applied in a flow cytometer. Every sample is split in two 
portions; one is stained with SYTO
®
 9 (green), the other with SYTO
®
 9 mixed with 
Propidiumiodid (red). Whereas SYTO
®
 9 diffuses in all cells, Propidiumiodid only diffuses 
through ruptured cell membranes causing a shift in the fluorescence spectrum. Thus, an 
overlay of the obtained dot plots of both portions reveals the percentage of dead cells. Dot 
plots of vivid and starved cells as well as heat and Isopropanol treated cells are depicted in 
Figure 3-14. Whereas both portions (green and red) of the vivid cells overlay directly, a shift 
can be observed for the treated cell samples. Hence, a clear discrimination between dead and 
vivid cells is possible for a sample of solely dead cells independent of the treatment method. 
This was also reported in literature before (Attfield et al., 2000; Deere et al., 1998; Garcia et 
al., 2006; Mernier et al., 2011). 
 
 
Figure 3-14: Determination of viability of Hansenula polymorpha pCoM11sc3625 samples 
analyzed by flow cytometry. Cells stained with SYTO
®
 9 (green) are overlaid by cells stained 
with SYTO
®
 9 and Propidiumiodid (red). The latter are gated. A) Vivid cells. B) Treatment 
with 40% of Isopropanol for 15 min. C) Treatment with 95 °C for 15 min. D) Starved cells 
(72 h without respiration activity).  
 
As fermentation samples are not homogenous dead or vivid, different preset concentrations of 
dead cell were analyzed. The obtained data is shown in Figure 3-15. Except for 0 and 100% 
dead cells, the measured value is slightly higher than the preset one. The overestimation of 
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dead cells could be a result of vivid cells being at the beginning of cell death. Propidiumiodid 
can diffuse into the ruptured but not yet dead cell causing a shift in the dot plot. The 
coefficient of determination was calculated as 0.9766. Thus, the LIVE/DEAD
®
 FungaLight
TM
 
Yeast Viability Kit applied in a flow cytometer proved to be accurate enough for this study 
and is used for viability measurements of H. polymorpha in subsequent experiments. 
 
 
Figure 3-15: Validation of preset dead cell concentrations of Hansenula polymorpha 
pCoM11sc3625 samples analyzed by flow cytometry. Cells were heat treated at 95 °C for 
15 min and mixed in set portions with untreated cells. Measured data points (open diamonds) 
are compared to theoretical values (continuous line).  
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Chapter 4 
4Configuration and Evaluation of Process Parameters of 
Reverse-flow Diafiltration 
RFD was designed to achieve maximal space-time-yield, prevent substrate loss and enable 
stable long-term operation. Both, mathematical calculations and experimental data, as well as 
process requirements are the design basis for the configuration discussed in this chapter. 
Whereas the initial configuration was conducted based on data of Hansenula polymorpha, 
data of CHO cultures were used for adjustment if mammalian cell lines are the target cells. An 
evaluation of the resulting configuration is conducted by comparison of the performance of 
RFD to conventional membrane-based cell retention systems. This chapter is partly published 
in Meier et. al (2014) and partly submitted to Biotechnology Progress (Meier et al., June 
2014). Experiments regarding transmembrane pressure increase were conducted by Frederike 
Carstensen (AVT.CVT) and Suzana Djeljadini in the context of her master thesis (2014). 
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4.1 Permeate Step 
During the permeate step (Figure 2-4 A), supernatant is withdrawn from the reactor through a 
membrane. To determine the maximum flux without formation of an irreversible fouling 
layer, flux step experiments were performed. Therefore, the irreversible TMP increase was 
measured for different fluxes (Figure 4-1).  
 
 
Figure 4-1: Flux step experiments for a microfiltration hollow–fiber membrane with a 
nominal pore size of 0.2 µm with culture broth of Hansenula polymorpha pCoM11sc3625 and 
CHO DG44. Conditions H. polymorpha: Flux time = 300 s, relaxation time = 300 s, no 
backflushing. Conditions CHO DG44: Flux time = 340 s, relaxation time = 20 s, backflushing 
time = 120 s.  
 
 
The critical TMP increase is defined as 45 Pa min
-1
 based on earlier experiments, and should 
not be exceeded in order to maintain stable conditions. According to Figure 4-1, a 
transmembrane flux of 21 L m
-2 
h
-1
 was determined to be the maximum flux if yeasts were 
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examined. The maximum flux is valid under the investigated conditions for this membrane: 
300 s filtration without backflushing, 300 s relaxation. The same filtration time of 300 s was 
set for the permeate step time (tP) of RFD (see also Table 4-1) to achieve comparable 
conditions to the flux step experiment. However, in RFD mode, fluxes twice as high as the 
maximum flux of the flux step experiments led to TMP increases below the critical value 
(data obtained by Frederike Carstensen, AVT.CVT, RWTH Aachen University). This is due 
to the worst-case conditions used in the flux step experiments. Therefore, the maximum flux 
over the membrane for RFD mode is approximately 40 L m
-2 
h
-1
.
 
Further calculations 
regarding necessary membrane area were based on the maximum flux
 
of 40 L m
-2 
h
-1
. 
The critical transmembrane flux for CHO cells using the same membrane is 9 L m
-2 
h
-1
 under 
the following conditions (Figure 4-1): 340 s filtration, 120 s backflushing and 20 s relaxation 
(Djeljadini, 2014). In contrast to yeast cells, conditions of RFD were applied for the 
determination of the critical transmembrane flux of CHO cells as RFD settings were know at 
that time point. Thus, a flux 9 L m
-2 
h
-1
 was expected to be the maximum applicable flux and 
used for the calculation of the necessary membrane area for the cultivation of CHO cells.  
As stated above the permeate step time (tP) of RFD was set to 300 s to achieve comparable 
TMP results to the flux step expierment. The setting of the permeate flux was calculated 
based on the dilution rate (D) and the filtered portion of the reactor outlet (1- NF). It was 
considered that the filtration time (tP) is only a part of the cycle time (tC) and thus, the flux has 
to be corrected by a time factor 
𝑡𝑐
𝑡𝑃
. The permeate volume gained during flushing (VF) 
(compare also Figure 2-4 B) was also accounted in the calculation of the permeate flux. The 
resulting formula is given in Table 4-1. 
 
4.2 Flushing Step 
During the flushing step (compare also Figure 2-4 B), permeate in the membrane is replace 
with medium so that only a minimal amount of permeate is pumped into the reactor during the 
subsequent feed step. However, the medium should not reach the permeate tubing behind the 
membrane in order to keep the permeate free from medium and to prevent a loss of substrate. 
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The time necessary for the tip feed flow to arrive at the end of the membrane (Figure 2-4 B) is 
defined as the flushing time (tF). It is given by the membrane length (L) and the maximum 
velocity of the feed flow (vmax) during the flushing step. The maximal velocity of a laminar 
flow in a tube is twice the average velocity (v̅) according to the law of Hagen-Poiseuille 
(Beitz et al., 1994): 
𝑡𝐹 =  
𝐿
𝑣𝑚𝑎𝑥
=
𝐿
2 ?̅?
            (4.1) 
The average velocity of fluid during the flushing step is defined as the flow generated by the 
pumps (→ FF,F • AM = FP,F • AM) divided by the cross section area of the membrane (AQ):  
?̅? =  
𝐹𝐹,𝐹∙𝐴𝑀
𝐴𝑄
             (4.2) 
The flushing volume (VF) is defined as the flushing time (tF) multiplied by the flow            
(FF,F • AM):  
𝑉𝐹 =  𝑡𝐹 ∙ 𝐹𝐹,𝐹 ∙ 𝐴𝑀           (4.3) 
Equations (4.1) and (4.2) into (4.3) results in: 
𝑉𝐹 =
𝐿∙𝐹𝐹,𝐹∙𝐴𝑀
2 ?̅?
=
𝐿∙𝐹𝐹,𝐹∙𝐴𝑀∙𝐴𝑄
2𝐹𝐹,𝐹∙𝐴𝑀
=  
1
2
𝐿 ∙ 𝐴𝑄        (4.4) 
The volume of the membrane (VM) is the the membrane length (L) multiplied by the cross 
section area of the membrane (AQ): 
 𝑉𝑀 = 𝐿 ∙ 𝐴𝑄            (4.5) 
The ratio (aF) of the flushing volume (VF) to the membrane volume (VM) is therefore: 
aF =  
VF
VM
=
1
2
L∙AQ
AQ∙L
= 0.5          (4.6) 
Hence, the flushing ratio is independent of membrane length and diameter.  
Configuration Reverse-flow Diafiltration   63 
  
The calculated value of aF = 0.5 applies to an ideal tube, it has to be validated for membranes, 
where pores were partially flushed. Experiments with dye were conducted to measure the 
flushing time needed for the dye to pass the membrane. The experimental value for aF was 
determined to be 0.7 as shown in Figure 4-2. This value was chosen for the RFD in 
subsequent biological experiments. 
 
 
Figure 4-2: Volume flushed per volume of the membrane lumen for different membrane 
length und fluxes. Methylene blue was flushed at different velocities; the time needed for the 
first drop of dye to pass the membrane was measured. The volume flushed was calculated 
based on the flux and the time, the membrane lumen was calculated on the membrane 
properties: PES hollow fiber membrane with a porosity of 40%, di = 1.5 mm, do = 2.35 mm. 
 
In the flushing step the tip of the medium flow should just reach the permeate tube. Thus, the 
permate and feed pump generate a laminar flow, where aF = 0.7 of the volume of the lumen 
(VLu) is flushed (Flushing volume VF). The flushing time (tF) was set to 20 s, which was half 
of the emptying time. The resulting equation to calculate the pump settings for the flushing 
step is given in Table 4-1. 
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4.3 Feed Step 
The feeding step (Figure 2-4 C) provides the bioreactor with nutrients. Simultaneously, the 
reverse direction of the feed flux through the membrane relative to the permeate flux removes 
the reversible cake layer formed during the permeate step. A uniform removal over the whole 
length of the membrane can be assumed as pressure loss is negligible for the used membrane 
length. For efficient removal the feed flux should generate a pressure of at least 0.3 bar 
(Baker, 2004). For the lowest dilution rate this can be achieved with a flux twice as high as 
the permeate flux. Therefore, the step time for the feed step (tFeed) was set to 150 s, which is 
half the time of the permeate step (tP).  
The feed flux is calculated based on the dilution rate (D) and the liquid volume (VL) in the 
reactor. The flux is corrected by a time factor as the feed is only conducted for 150 s (tFeed) of 
the whole cycle time (tC). Furthermore, the permeate volume in the feed tubing due to the 
emptying (Figure 2-4 D) and flushing step (Figure 2-4 B) was also accounted for (+VE – VF). 
The resulting equation for the pump settings in the feed step is given in Table 4-1. 
 
4.4 Emptying Step 
During the emptying step (Figure 2-4 D), medium inside the membrane is replaced by 
permeate to prevent mixing with medium during the subsequent permeate step (Figure 2-4 A). 
For the emptying step it was assumed that: i) the flow inside the membrane is laminar, ii) the 
velocity profile (v(z)) is linear, and iii) the membrane pores were partially flushed (Bütehorn 
et al., 2011). Thus, the membrane diameter flushed (d) is larger than the membrane diameter 
without pores (di) and smaller than the membrane diameter with pores (do). If the feed 
(→ FF,E • AM) and permeate pump (→ FP,E • AM) are emptying the membrane (Figure 2-4 D), 
the emptying time (tE) for a membrane with length (L) and the velocity profile results in:  
𝑑𝑡𝐸 =  𝑣(𝑧) ∙ 𝑑𝑧      ,0 < 𝑧 < 𝐿      (4.7) 
 𝑣(𝑧) =  
(𝐹𝐹,𝐸−𝐹𝑃,𝐸)𝐴𝑀
1
4⁄ 𝜋𝑑
2𝐿
𝑧 +
𝐹𝑃,𝐸∙𝐴𝑀
1
4⁄ 𝜋𝑑
2    , 𝑑𝑖 < 𝑑 < 𝑑𝑜     (4.8) 
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Insertion of equation (4.8) in (4.7) and integration leads to: 
𝑡𝐸 =  (𝑙𝑜𝑔 (
(𝐹𝐹,𝐸−𝐹𝑃,𝐸)𝐴𝑀
1
4⁄ 𝜋𝑑
2 +
𝐹𝑃,𝐸∙𝐴𝑀
1
4⁄ 𝜋𝑑
2 ) − 𝑙𝑜𝑔 (
𝐹𝑃,𝐸∙𝐴𝑀
1
4⁄ 𝜋𝑑
2 )) (
(𝐹𝐹,𝐸−𝐹𝑃,𝐸)𝐴𝑀
1
4⁄ 𝜋𝑑
2 )⁄ , 𝑑𝑖 < 𝑑 < 𝑑𝑜 (4.9) 
The time necessary for the membrane to be completely emptied (tE) was calculated using 
equation (4.9) with different ratios of feed flux (FF,E) and permeate flux (FP,E).  
 
 
Figure 4-3: Calculation of time needed for membrane emptying step depending on which 
portion of the membrane pores are flushed. According to Bütehorn et al. (2011), this portion 
is approximately 
1
3
 of all membrane pores. Membrane properties: di = 1.5 mm, do = 2.35 mm. 
Flux generated by feed pump = 50 L m
-2
 h
-1
 (reverse direction), flux generated by permeate 
pump = 10 L m
-2 
h
-1
 (Feed flux / permeate flux ratio of 5:1) or 45 L m
-2
 h
-1
 (Feed flux / 
permeate flux ratio of 10:9), respectively.  
 
For example, the emptying time (tE) for a feed flux (FF) to permeate flux (FP) ratio of 5:1 and 
10:9 as a function of the diameter flushed is shown in Figure 4-3. The feed flux during 
emptying is fixed at 50 L m
-2
 h
-1
, which is higher than the critical flux but leads to an 
emptying time as short as possible. As this flux is applied only for a short period the impact 
on the membrane is negligible. According to Bütehorn et al. (2011), approxitmatly 
1
3
 of all 
Configuration Reverse-flow Diafiltration   66 
  
membrane pores are flushed. Thus, 40 s or 19 s are necessary to empty the membrane if a feed 
flux to permeate flux ratio of 5:1 or 10:9, respectively,  is applied. As only 
1
3
 of membrane 
pores are flushed, the remaining 
2
3
 of pores have to be filled with permeate recovered from the 
fermenter. Hence, a driving force in the form of a pressure difference over the membrane is 
needed. If the feed and permeate fluxes are almost equal, hardly no driving force over the 
membrane exists. Smaller ratios result in greater pressure differences, but also in longer 
emptying times and a worse overall process performance. Therefore, a ratio of 5:1 and 
thereby an emptying time of 40 s was determined to be a good compromise between short 
emptying time and high driving force (Table 4-1).  
The overall emptying volume (VE) can be calculated with the chosen emptying time 
(tE = 40 s) and the feed and permeate pump flow. The ratio between the emptying volume 
(VE) and the membrane volume (VM) is defined as aE. For the selected feed flux to permeate 
flux ratio of 5:1, aE equals 1.69. The resulting equation for the settings of the feed and 
permeate pump in the emptying step is given in Table 4-1. 
 
4.5  Step Times and Fluxes for Overall Processes 
RFD was configured in this chapter with focus on the maximum flux over the membrane and 
avoidance of a mixture of permeate and fresh medium. Furthermore, every dilution rate can 
be applied exactly, as time factors and the small volumes of the emptying and flushing step 
were considers for the feed and permeate step. The relevant equations to apply RFD are 
summarized in Table 4-1 and presented in the most general mode. Thus, membrane area (AM), 
dilution rate (D) and retention rate (1-NF) as well as step times can be chosen freely. 
However, steps times as given in the table are recommended for microbial cultures. Table 4-1 
is the basis for all RFD experiments conducted in this thesis.  
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Table 4-1: Calculation of fluxes and applied step times for all four steps of RFD.  
Step 
Time   
[s] 
Flux 
 [L m
-2
 h
-1
] 
Permeate 
 
tP = 300 𝐹𝑃,𝑃 =
𝐷 𝑉𝐿(1 − 𝑁𝐹) 𝑡𝐶 − 𝑉𝐹 
𝐴𝑀𝑡𝑃
 
Flushing 
 
tF = 20 𝐹𝑃,𝐹 = 𝐹𝐹,𝐹 =
𝑎𝐹𝑉𝐿𝑢
𝐴𝑀𝑡𝐹
=  
𝑉𝐹
𝐴𝑀𝑡𝐹
 
Feed 
 
tFeed = 150 𝐹𝐹,𝐹𝑒𝑒𝑑 =
𝐷 𝑉𝐿 𝑡𝐶 − 𝑉𝐹 + 𝑉𝐸  
𝐴𝑀𝑡𝐹𝑒𝑒𝑑
 
Emptying 
 
tE = 40 
 
𝐹𝐹,𝐸 =
𝑎𝐸𝑉𝑀
𝐴𝑀𝑡𝐸
=
𝑉𝐸
𝐴𝑀𝑡𝐸
 
𝐹𝑃,𝐸 =
𝑎𝐸𝑉𝑀
5𝐴𝑀𝑡𝐸
=
𝑉𝐸
5𝐴𝑀𝑡𝐸
 
 
4.6 Benchmark of Reverse-flow Diafiltration  
In RFD small amounts of permate are pumped backed into the reactor during the feeding step 
as there is a mixture of permate and feed in the feed tubing caused by the emptying step 
(Figure 2-4 D). The amount of pemerate pumped back should be small as the permate 
contains high value products. To evaluate this aspect, RFD is compared to conventional 
backflushing membrane bioreactors, where permeate is used to reduce the fouling layer 
The permeate volume pumped back into the bioreactor in RFD equals the volume pumped 
during the emptying step (VE) minus the volume of the membrane (VM), which was filled with 
medium before. This volume subtracted from the total permeate withdrawn over the 
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membrane (FP • AM • tP) is defined as gained permeate (VP,g). The amount of gained permeate 
per total permeate was plotted over the dilution rate in Figure 4-4 for one and three 
membranes applied. The selected feed flux to permeate flux ratio was set to 5:1 as discussed 
in chapter 4.4. 
 
 
Figure 4-4: Gained permeate per total gained permeate for different dilution rates in 
comparison to conventional backflushing. Permeate is pumped back into the fermenter due to 
emptying and flushing steps or backflushing. RFD conditions: 1 or 3 microfiltration 
membranes with 1 m length each and a nominal pore size of 0.2 µm, NF = 0.5, aE = 1.69, 
aF = 0.7, tC = 510 s, feed flux / permeate flux of 5 : 1. 
 
The maximum specific flow rate over the membrane, determined in chapter 4.1, limits the 
applied dilution rate if the membrane area is fixed. This is indicated in Figure 4-4 by two 
vertical lines. One membrane applied allows dilution rates up to D = 0.22 h
-1
, three 
membranes applied triple the maximum dilution rate to D = 0.66 h
-1
. Furthermore, Figure 4-4 
contains a striped area depicting how much permeate is lost due to backflushing in full scale 
hollow fiber membrane bioreactors for waste water treatment. Data for minimum and 
maximum value is taken from Zsirai et al. (2012). The values of RFD at the maximum 
dilution rates are above the striped area. Hence, if the selected membrane area is as small as 
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possible, RFD recovers more permeate than full scale hollow fiber membrane bioreactors that 
apply backflushing. 
Evaluation of membrane-based bioreactors is often conducted based on the membrane area. 
The critical transmembrane flux determined in chapter 4.1 defines the required membrane 
area of RFD. The critical flux specifies the maximum volume [L] that can be filtered by the 
membrane area [m
-2
] per time [h
-1
]. Thus, if the factor time is provided in terms of the 
perfusion rate [d
-1
], the specific filtration area [m
-1
] indicating the membrane area [m
2
] per 
filtered volume [L] can be calculated based on the critical flux. The result of this calculation 
for CHO cells with a critical flux of 9 L m
-2
 h
-1
 (Figure 4-1) is given in Figure 4-5 as a 
continuous line for RFD. Furthermore, Figure 4-5 depicts data for other commonly used 
perfusion systems applying membrane based cell retention systems taken from reviews by 
Voisard et al. (2003) and Su et al. (2010). Here, data points represent applied specific 
filtration areas in single studies; a linear fit of the data is shown as dashed-dotted or dashed 
line for the rotating filter and cross-flow membranes, respectively. Recently, the 
commercially available ATF system (Alternating Tangential Flow, Refine Technology, New 
Jersey, USA) is widely applied in industry. As data in literature hardly exist, theoretical data 
(Su, 2010) was used for the correlation of the specific filtration area and the perfusion rate 
(dotted line). Although the data points scatter as different media and filtration settings were 
used, the necessary filtration area for cross-flow membranes and the ATF system is larger 
than the calculated values for RFD. In contrast, rotating filters were applied with less 
membrane area. However, it was reported that fouling is a major issue (Su, 2010; Voisard et 
al., 2003) for commonly available rotating filters. Rotating filter screens are made of stainless 
steel with pore sizes larger than the average cell size. As stainless steel is highly positively 
charged, cell debris and proteins are likely to stick to the steel enhancing membrane fouling 
and reducing antibody transmission through the filter (Su, 2010; Voisard et al., 2003). Thus, 
the required membrane area, based on the critical flux of 9 L m
-2
 h
-1
 for CHO cells for the 
chosen membrane-medium combination, is competitive with commercially available 
membrane-based cell retention systems. 
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Figure 4-5: Specific filtration areas of membranes in perfusion cultures applying different cell 
retention systems. The continuous line (reverse-flow diafiltration) was calculated based on the 
critical flow rate. Data points for the ATF system (white squares) and the theoretical data for 
the calculation of the dotted line (ATF) were taken from the review paper of Su et al. (2010). 
Data points for cross-flow (black circles) were taken from the review paper Voisard et al. 
(2003) and fitted linear (dashed line). Rotating filter data (grey diamonds) was also taken 
from Voisard et al. (2003) and fitted linear (dashed-dotted line). The media used for in data 
from the review papers were from all kinds: Dulbecco’s modified Eagle’s medium with          
5 – 10% fetal calf serum, alone or mixed with Ham’s nutrient mixture F-12. One study used 
Grace’s powdered medium, one study Roswell Park Memorial Institute basal medium. 
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Chapter 5 
5Production of (Single-chain) Antibodies in a Reverse-flow 
Diafiltration Membrane Bioreactor 
This chapter focuses on the application of RFD in a membrane bioreactor cultivating the yeast 
H. polymorpha as well as the mammalian cell line CHO DG44. Therefore, the influence of 
RFD on yeast cell viability was examined in the first part. Furthermore, the production of 
single-chain antibodies secreted by H. polymorpha is investigated in a continuous culture 
using RFD. In the second part applicability of RFD with CHO cells is examined by a 
biocompatibility test of the used polymer materials. Also a perfusion culture using RFD for 
the production of human full length antibodies secreted by CHO is conducted. Key aspects for 
the evaluation of RFD with yeast and mammalian cells are product yield, viability of cells as 
well as long term stability indicated by the filtration performance. Experiments discussed in 
this chapter were performed by Christoph Scheeren (2012), Anne Worsch (2013) und Suzana 
Djeljadini (2014). A part of this chapter was published in Meier et al. (2014), another part is 
submitted to Biotechnology Progress (June 2014). 
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5.1 Production of Single-chain Antibodies Secreted by 
Yeasts 
5.1.1 Influence of Reverse-flow Diafiltration on Yeast Cell Viability 
A continuous fermentation without cell retention was performed in acceleration-stat mode 
(Paalme et al., 1995) as a reference for the RFD process. Results are illustrated in Figure 5-1. 
With 20 g L
-1
 glycerol as a carbon source, a constant dry cell weight between 10 and 13 g L
-1
 
was observed and, therefore, a yield of approximately 0.55 could be achieved. The washout 
point was around 0.32 h
-1
, but slightly delayed due to acceleration-stat operating mode. The 
antibody concentration was consistently in the range of 0.12–0.15 g L-1. Until the washout 
point, the glycerol concentration was close to zero as anticipated for a continuous 
fermentation limited by the carbon source (Figure 5-1 A). As expected, the oxygen transfer 
rate increased linearly with the dilution rate (Figure 5-1 B). The vivid cell concentration was 
86% for a dilution rate of 0.08 h
-1
 and increased to 100% for dilution rates of 0.26 h
-1
 or 
higher, where the exchange of cells in the reactor is faster. The dead cell concentration was in 
agreement with the vivid cell concentration (Figure 5-1 C).  
To investigate the influence of pulsed feeding and the membrane on cell viability, RFD was 
applied, but the gained permeate was directed back into the fermenter, creating a shortcut 
(Figure 2-6, dashed line). Consequently, removal of fluid from the fermenter system was only 
conducted through the non-filtered product stream. Thus, feed streams and non-filtered 
product streams in this particular experiment equal a continuous fermentation without cell 
retention, however, were pumped in a pulsed mode. The viabilities of cells with pulsed 
feeding and without cell retention did not differ significantly from the reference (Figure 5-1 
C). Dry cell weight, antibody concentration, glycerol concentration, as well as the oxygen 
transfer rate, were also very similar to Figure 5-1 A & B and, thus, not shown for clarity 
reasons. 
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Figure 5-1: Continuous acceleration-stat fermentation of Hansenula polymorpha 
pCoM11sc3625 with (A, B, C) and without (C) reverse-flow diafiltration. Culture conditions: 
synthetic medium Syn-6, 20 g L
-1
 glycerol, VL = 1.5 L, pO2 > 30%, n = 500 – 1800 rpm, 
q = 1 vvm, pH value of 5.5, T = 37 °C, acceleration rate a = 0.001 h
-2
 for D = 0.08 – 0.34 h-1. 
A) Dry cell weight (DCW) and antibody concentration. B) Oxygen transfer rate (OTR). C) 
Viability of cells measured by flow cytometry.  
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5.1.2 Production of Single-chain Antibodies in a Reverse-flow Diafiltration 
Membrane Bioreactor 
Continuous fermentations with 50% cell retention were performed in RFD mode. Results are 
summarized in Figure 5-2. The dry cell weight consistently ranged between 20 – 22 g L-1, 
which was nearly twice as high as without cell retention (Figure 5- A and  Figure 5-2 A). 
Also, the washout point approximately doubled as a dilution rate of 0.65 h
-1
 was achieved 
(Figure 5-2 A). Doubling of these values is expected for 50% cell retention. Glycerol was not 
detectable, neither in the broth nor in the permeate (Figure 5-2 A). Since the presence of 
glycerol in the permeate would be an indication of mixing of the permeate and medium, the 
absence of glycerol demonstrates successful emptying and flushing.  
The average antibody concentration in broth and permeate was approximately 0.2 g L
-1
 
(Figure 5-2 A). This is unexpectedly high as a constant product concentration over a range of 
dilution rates as measured in Figure 5-1 A implies growth associate product formation. The 
growth rate of the biomass does not change if cell retention is applied. Thus, cells have the 
same growth rate for the same dilution rate in fermentation with and without cell retention. 
Hence, the product concentration should be similar in both experiments. The difference 
between the antibody concentration in the reference fermentation (Figure 5-1 A) and the 
fermentation with cell retention could be explained by a higher number of dead cells in the 
experiment with cell retention. For a dilution rate of 0.1 h
-1
, nearly 30% of cells died if 
retained (Figure 5-2 C). This value was nearly constant until the washout point. The 
percentages of vivid and dead cells are coherent. Cell disruption experiments demonstrated 
that a fraction of antibodies remain in and attached to the cells. Therefore, a higher 
concentration of dead cells implies greater release of antibodies into the supernatant.   
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Figure 5-2: Continuous fermentation of Hansenula polymorpha pCoM11sc3625 with reverse-
flow diafiltration. Culture conditions: synthetic medium Syn-6, 20 g L
-1
 glycerol, VL = 1.5 L, 
pO2 > 30%, n = 500 – 1800 rpm, q = 1 - 3 vvm, pH value of 5.5, T = 37 °C, 3 parallel 
microfiltration membranes with 1 m length each and a nominal pore size of 0.2µm, aE = 1.69, 
aF = 0.7, NF = 0.5, tC = 510s. A) Dry cell weight (DCW), glycerol concentration and antibody 
concentration (average of permeate and broth). B) Oxygen transfer rate (OTR). C) Antibody 
transmission, dead and vivid cells and transmembrane pressure (TMP) increase.   
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As expected, the oxygen transfer rate increased linearly with dilution rate (Figure 5-2 B). 
OTR values with or without cell retention were comparable at the same dilution rate (Figure 
5-1 B and Figure 5-2 B). Antibody transmission was constantly high, ranging from 70 – 80% 
(Figure 5-2 C). However, antibody transmission decreased slightly with higher dilution rates 
due to a slightly larger fouling layer. The increase in TMP also became greater with higher 
dilution rates, but remained below the critical TMP increase of 45 Pa min
-1
 over the whole 
range of dilution rates. Therefore, a stable filtration process could be maintained for all 
applied dilution rates. Hence, it can be suggested that long-term application of RFD would 
show constant performance for high dilution rates. Direct comparison of productivity, cell 
viability or filtration stability from the current study to literature values cannot be done since 
only mammalian cultures for antibody production have been investigated so far.   
 
 
Figure 5-3: Comparison of space-time-yields of a continuous acceleration-stat fermentation 
and a continuous fermentation with reverse-flow diafiltration of Hansenula polymorpha 
pCoM11sc3625. Culture conditions: synthetic medium Syn-6, 20 g L
-1
 glycerol, VL = 1.5 L, 
pO2 > 30%, n = 500 – 1800 rpm, q = 1 - 3 vvm, pH value of 5.5, T = 37 °C, 1 to 3 parallel 
microfiltration membranes with 1 m length each and a nominal pore size of 0.2 µm, 
acceleration rate  a = 0.001 h
-1
 for D = 0.08 – 0.34 h-1, aE = 1.69, aF = 0.7, NF = 0.5, 
tC = 510s.  
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Evaluation of RFD from an economic standpoint was done by examining the space-time-yield 
of antibodies gained with or without cell retention (Figure 5-3). The space-time-yield from the 
reference fermentation without cell retention increased linearly from approximately    
0.01 g L
-1
 h
-1
 at a dilution rate of 0.08 h
-1
 to 0.04 g L
-1
 h
-1
 at a dilution rate of 0.32 h
-1
. 
Fermentation with RFD mode led to a space-time-yield of 0.02 g L
-1
 h
-1
 at a dilution rate of 
0.1 h
-1
 and 0.12 g L
-1
 h
-1
 at a dilution rate of 0.6 h
-1
. Consequently, a stable filtration process 
could be achieved for high dilution rates, leading to a triplication of the space-time-yield. 
 
 
5.2 Production of Antibodies Secreted by Mammalian Cells 
5.2.1 Biocompatibility of Reverse-flow Diafiltration Materials 
Plastic materials can leach out chemical compounds which may be toxic above a certain 
concentration for microbial and cell cultures. As it is not possible to predict the toxicity of the 
leached compounds for individual cultures, a biocompatibility test should be conducted prior 
to each new combination of culture and plastic material. Comparison of growth behaviors of 
culture in the presence and absence of plastic materials is a common biocompatibility test 
setup (Meier et al., 2013). The used plastic materials in this study namely the polyethersulfone 
membrane, heat shrink tubing and silicon tubing were added separately to a culture of CHO 
DG44 cells in T75 flasks. Viable cell densities of these cultures were compared to the viable 
cell density of a culture without additional plastic material. Figure 5-4 depicts the result. After 
4 days of culture the viable cell density of all cultures approximately quadrupled. No 
significant difference could be noticed between the cultures in presence or absence of the 
examined plastic materials. 
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Figure 5-4: Investigation of biocompatibility of applied materials in the perfusion culture 
setup applying reverse-flow diafiltration and CHO DG44 cells. Culture conditions: 
PowerCHO 2 medium with 4 mM L-glutamine, T75 flask, T = 37 °C, 5% CO2, VL = 20 mL. 
 
 
 
5.2.2 Production of Antibodies in a Batch Culture 
A batch culture of CHO DG44 cells without a membrane module was conducted as a 
reference for the subsequent perfusion culture applying RFD. The obtained data is depicted in 
Figure 5-5. The viable cell concentration increases from 0.1∙106 cells mL-1 to a maximum of 
3.5∙106 cells mL-1 after 286 h (Figure 5-5 A). After a stagnation phase lasting until 387 h the 
viable cell concentration starts to decrease. The capacity signal is a mixed signal of viable 
biomass and metabolic activities. It has a similar progress as the viable cell concentration in 
the conducted batch experiment (Figure 5-5 A). It increases simultaneously with the viable 
cell concentration until 288 h and decreases afterwards with a small peak at 378 h. The peak 
could indicate a change of the metabolic activity as apoptosis of the cell line starts 
approximately at that time point. This can also be noticed in the viability of the cell culture 
dropping below 80% (Figure 5-5 B).  
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Figure 5-5: Batch culture of CHO DG44 cells expressing a H10 antibody. Culture conditions: 
PowerCHO 2 medium with 4 mM L-glutamine, T = 37 °C, VL = 1 L, n = 120 rpm, 
pO2 > 40%, pH of value = 6.8. A) Viable cell concentration and capacity. B) Viability 
C) Glucose, glutamine and lactate concentration.  
 
The H10 antibody was efficiently produced and accumulated up to 156 mg L
-1
 after 317 h and 
remained constant until 368 h (Figure 5-5 B). Following, a steep drop in H10 concentration to 
114 mg L
-1
 that occurred at 411 h, the antibody concentration finally increased again and 
reached 155 mg L
-1
 at the end of the cultivation (430 h). The concentration drop could have 
been caused by degradation. The subsequent increase may result from rupturing cells due to 
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apotosis releasing antibodies. The sharp decrease of product formation followed by an 
increase was observed during several cultivations of this specific CHO DG44 cell line 
according to Tanja Holland (Fraunhofer IME). The glucose concentration steadily decreases 
from its initial value of 6.6 g L
-1
 and was fully depleted after 317 h (Figure 5-5 C). The 
glutamine concentration decreased from initially 0.64 g L
-1
 and was no longer detectable in 
the medium after 244 h (Figure 5-5 C). The maximum concentration of the byproduct lactate 
was 1.8 g L
-1
, which was reached after 244 h and remained constant (Figure 5-5 C).  
The integrity of the H10 antibody chains was verified by a reduced western blot that is shown 
in Figure 5-6. Protein bands of heavy and light chain at 50 and 25 kDa, respectively indicate 
the correct protein sizes displayed in Figure 5-5 B. More degradation products became visible 
in samples corresponding to later time points of the cultivation, most likely because of the 
higher antibody concentration applied.  
 
 
Figure 5-6: Reduced western blot of batch samples. 20 µL sample volume (supernatant), 4 µL 
standard (50 µg mL
-1
 H10), 8 µL pre-stained marker (Fermentas), HC: heavy chain, LC: light 
chain. 
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5.2.3 Production of Antibodies in a Reverse-Flow Diafiltration Membrane 
Bioreactor 
Until now, RFD has only been described for microbial culture processes (Carstensen et al., 
2013; Carstensen et al., 2012b; Meier et al., 2014; Meier et al., May 2014). However, 
recombinant protein production in mammalian cell lines could also be efficiently carried out 
using RFD. In mammalian cell terminology continuous cultures applying cell retention are 
called perfusion cultures. Perfusion cultures are not C-source limited as continuous cultures 
for microbial processes and therefore, perfusion cultures do not reach steady state. Thus, 
results of perfusion cultures are plotted over time in contrast to microbial continuous cultures, 
which are plotted time independent over the dilution rate. 
 A perfusion culture of CHO DG44 cells applying RFD with a retention rate of 90% 
(NF = 0.1) is shown in Figure 5-7. The first days of the perfusion culture were conducted in 
batch mode until a viable cell concentration of 1.8∙106 cells mL-1 was achieved (Figure 5-7 A) 
after 114 h. The increase of the viable cell concentration of the perfusion culture until 114 h 
was comparable with the data that was obtained for the batch culture of CHO DG44 cells 
without a membrane module (Figure 5-5 A and Figure 5-7 A), confirming the results of the 
biocompatibility test (Figure 5-4). At 114 h, the perfusion mode was started with a dilution 
rate of D = 0.5 d
-1. The viable cell density increased to 4.5∙106 cells mL-1 at 146 h and 
remained rather constant at 3.9 – 4.5∙106 cells mL-1 until 216 h. When the dilution rate was set 
to D = 1 d
-1
 at 216 h the viable cell concentration remained high at 4.2 – 4.6∙106 cells mL-1 
until 340 h. The temporary drop of the viable cell concentration was caused by two short 
operation failures of Labview cause a failure of both pumps between 170 h and 242 h which 
led to a dilution of the culture. A further increase of the dilution rate to D = 2 d
-1
 at 383 h 
cause a decrease of viable cell density of finally 1.5∙106 cells mL-1 at 428 h indicating a 
dilution of the culture. The maximum growth rate (µmax) of this CHO DG44 cell line is 0.672 
d
-1
, thus,  dilution rates (Dmax) up to 6 .72 d
-1
 (Dmax = 
µ𝑚𝑎𝑥
𝑁𝐹
 ) should be possible.  
The dilution rate of D = 0.5 d
-1
, 1 d
-1
 and 2 d
-1
 correspond to permeate flow rates of     
4.2 L m
-2
 h
-1
, 8.6 L m
-2
 h
-1
 and 18.2 L m
-2
 h
-1
, respectively (Table 2-6). Whereas the flow rates 
for D = 0.5 d
-1
 and 1 d
-1
 are below the critical flow rate of 9 L m
-2
 h
-1
 (Figure 4-1), the flow 
rate for D = 2 d
-1
 is above the critical value. Thus, membrane fouling was expected to occur. 
Concurrent membrane blocking causes a decrease of the amount of permeate gained over the 
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membrane. Data obtained by the permeate balance (data not shown) confirm an increasing 
deviation of the set permeate and the gained permeate. As a result, the volume of the non-
filtered product stream increased because the corresponding pump was controlled by the 
balance weighing the bioreactor. Hence, the retention rate decreased and, thus, a lower cell 
density was obtained.  
For every dilution rate a distinct transmembrane pressure plateau could be measured (Figure 
5-7 A). The plateaus were at 0.13 bar, 0.28 bar and 0.34 bar for the dilution rates of  
D = 0.5 d
-1
, 1 d
-1
 and 2 d
-1
, respectively. The transmembrane pressure nearly doubled when 
the dilution rate was doubled for the first time, but the increase in the transmembrane pressure 
was only 20% at the second increase of the dilution rate. This indicates membrane blocking at 
D = 2 d
-1
 as the pressure required to generate the flux could not be adjusted accurately. 
The viability of the cell population remained constant above 90% during the entire culture 
time of 432 h indicating that optimal growth conditions were sustained (Figure 5-7 B). The 
antibody concentrations in the reactor and in the harvest were quantified by a Resonance 
Surface Plasmon Measurement (Figure 5-7 B). During dilution rates of D = 0.5 d
-1
 and 1 d
-1
 
the antibody concentration increased in both fractions, but the antibody concentration in the 
harvest was always proportionally lower. The antibody transmission ranged between 40 and 
60%. Clincke et al. (Clincke et al., 2013b) reported that commercially available membrane-
based cell retention systems show antibody transmission of 10% to 60% after a comparable 
perfusion time of 18 days. In this perfusion experiment maximum antibody concentrations of 
189 mg L
-1
 and 122 mg L
-1
 were determined in the reactor and in the harvest, respectively. 
These values are comparable to those quantified of the batch culture. A sharp decrease in the 
antibody concentration accompanies the increase of the dilution rate to D = 2 d
-1
 according to 
the trend of the viable cell density. 
Glucose and glutamine concentrations decreased during the batch phase to values of 4.6 g L
-1
 
and 0.2 g L
-1
, respectively (Figure 5-7 C). After switching to the perfusion culture glucose and 
glutamine concentrations shortly increased. Then, the glucose concentration steadily 
decreased to a value of to 2.6 g L
-1
 at 240 h and thereafter remained constant until 340 h, 
whereas the glutamine concentration alternates around 0.2 g L
-1
 until 340 h. The fluctuations 
of metabolites can be caused by the pulsed feeding mode of RFD. The subsequent increase of 
the dilution rate to D = 2 d
-1
 caused an increase of the glutamine and glucose concentrations 
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corresponding to the decrease of the viable cell concentration. The lactate concentration 
increases during the batch phase to a value of 1.4 g L
-1
 and remains constant until the dilution 
rate was set to D = 2 d
-1
 when it decreased.  
 
 
Figure 5-7: Perfusion culture of CHO DG44 cells expressing a H10 antibody applying 
reverse-flow diafiltration. Culture conditions: PowerCHO 2 medium with 4 mM L-glutamine, 
T = 37 °C, VL = 1 L, n = 120 rpm, pO2 > 40%, pH value of 6.8, tC = 510 s, aE = 1.89, aF = 0.7, 
NF = 0.1. A) Viable cell concentration and transmembrane pressure (data for transition zones 
not monitored). B) Viability and antibody concentrations C) Glucose, glutamine and lactate. 
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A reducing western blot was conducted for one sample from each dilution rate to verify 
integrity of the antibody (Figure 5-8). Bands of heavy and light chain could be detected for all 
samples at the expected sizes of 50 and 25 kDa, respectively.  
 
 
Figure 5-8: Reduced western blot of samples from the perfusion culture. 20 µL sample 
volume (supernatant), 4 µL standard (50 µg mL
-1
 H10), 8 µL pre-stained Marker (Fermentas), 
HC: heavy chain, LC: light chain, R: samples reactor, H: samples harvest.  
 
Long-term stability and high space-time yield was proven for RFD culturing yeast or CHO 
cells. Stable conditions in terms of concentrations and filtration performance were achieved as 
long as the critical flow rate was not exceeded. Antibody transmission was comparable to 
published data (Clincke et al., 2013b) for commercially available membrane based cell 
retention systems. In case higher dilution rates as applied here or larger fermenter volumes are 
required, a bigger membrane area would have to be applied. 
An industrial application would require a scale up from the investigated 3 L reactor to      
100 – 1000 L reactors with dilution rates of 1 reactor volume per day. The maximum flux in 
this study is 21 L m
-2
 h
-1
 or 9 L m
-2
 h
-1
 for H. polymorpha or CHO cells, respectively. Hence, 
the necessary filtration area has to be six-fold to 180-fold higher for a reactor with 100 L or 
1000 L filling volume, respectively. Using hollow fiber bundles can solve this issue. In 
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membrane bundles a uniform driving force in every membrane has to be provided in order to 
guarantee an effective flushing and emptying. Several bundles spread over the reactor volume 
will lead to a good distribution of medium avoiding areas with high concentration. 
As the application of single-use bioreactors is an emerging trend especially in industry, an 
integration of submerged membranes in single-use bags and disposable cylindrical vessels 
was considered. Attachment of membranes in single-use bags was already successfully 
investigated in the diploma thesis of Lukas Beckmann (Beckmann, 2013). RFD is an easy 
applicable process with low investment cost. Only the membranes, two ports and a disposable 
bracket at the bottom of the culture vessel are required modifications. Hence, an integration of 
RFD in single-use bioreactors is feasible in economic and technical terms. 
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Chapter 6 
6Modelling and Simulation of Reverse-flow Diafiltration 
Models and simulations are supportive tools for process optimization. The experimental effort 
can be reduced drastically if establish models predict the progress and the outcome of 
potential experiments. Especially experiments with mammalian cell cultures are time 
consuming, cost-intensive and accident sensitive and, thus, particularly appropriate for the 
application of simulation tools. In this chapter a model for the batch cultivation and reverse-
flow diafiltration of mammalian cells conducted in this thesis is developed. The calculation of 
constants and the estimation of parameters using a Monte Carlo simulation are based on batch 
data. The developed model is used to determine an optimized perfusion strategy to increase 
the accumulated product concentration. The main results discussed in this chapter are 
acquired in the master thesis of Suzana Djeljadini (Djeljadini, 2014).  
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Figure 6-1: System boundaries and relevant variables of RFD. Feed flow (?̇?𝐹), permeate 
flow (?̇?𝑃) and non-filtered product stream flow (?̇?𝑁𝐹), filling volume (VL) concentration of 
biomass (X), product (P), substrates glucose (SGluc) and glutamine (SGlut), byproducts 
lactate (BPL) and ammonium (BPA) as well as concentrations in the feed glucose (SF,Gluc) and 
glutamine (SF,Glut).   
 
6.1 Model development of a reverse-flow diafiltration 
The developed model focuses on the biological part of the RFD process. Therefore, the 
system boundary was chosen around the bioreactor as shown in Figure 6-1. The variables of 
the model describe concentrations and, thus, are determined by mass balances. In general, 
balances for an extensive property such as mass (𝛹) consist of a conversion term (∑ ).𝛹 and the 
flow of the extensive property in (+?̇?𝒊𝒏) and out (-?̇?𝒐𝒖𝒕) of the system: 
𝑑(𝛹)
𝑑𝑡
= ∑ .𝛹 + ?̇?𝒊𝒏 − ?̇?𝒐𝒖𝒕          (6.1) 
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Substitution of mass by concentrations multiplied by the volume of the system (𝛹 = 𝑐𝛹 ∙ 𝑉𝐿) 
and adaption of equation 6.1 to the flows of bioreactor system shown in Figure 6-1 (?̇?𝐹 , ?̇?𝑃 
and ?̇?𝑁𝐹) results in: 
𝑑(𝑐𝛹∙𝑉𝐿)
𝑑𝑡
= ∑ .𝛹 + ?̇?𝑭 ∙ 𝒄𝜳,𝑭 − ?̇?𝑷 ∙ 𝒄𝜳,𝑷 − ?̇?𝑵𝑭 ∙ 𝒄𝜳,𝑵𝑭     (6.2) 
𝑑𝑐𝛹
𝑑𝑡
∙ 𝑉𝐿 +
𝑑𝑉𝐿
𝑑𝑡
∙ 𝑐𝛹 = ∑ .𝛹 + ?̇?𝑭 ∙ 𝒄𝜳,𝑭 − ?̇?𝑷 ∙ 𝒄𝜳,𝑷 − ?̇?𝑵𝑭 ∙ 𝒄𝜳,𝑵𝑭    (6.3)  
The filling volume of the bioreactor is assumed to be constant (
𝑑𝑉𝐿
𝑑𝑡
= 0): 
𝑑𝒄𝜳
𝑑𝑡
= ∑ .𝛹 +
?̇?𝑭
𝑽𝑳
∙ 𝒄𝜳,𝑭 −
?̇?𝑷
𝑽𝑳
∙ 𝒄𝜳,𝑷 −
?̇?𝑵𝑭
𝑽𝑳
∙ 𝒄𝜳,𝑵𝑭       (6.4) 
The flow into the bioreactor (?̇?𝐹) and the flow out of the bioreactor (Permeate ?̇?𝑃 and non-
filtered ?̇?𝑁𝐹) is set equal, which is a condition for continuous cultures. The ratio between the 
permeate flow (?̇?𝑃) and the non-filtered flow (?̇?𝑁𝐹) is defined as non-filtered ratio (NF):  
?̇?𝐹 = ?̇?𝑁𝐹 + ?̇?𝑃 = ?̇? ∙ 𝑁𝐹 + ?̇? ∙ (1 − 𝑁𝐹) = ?̇?        (6.5) 
In chemical engineering the residence time (τ) is used to describe the average time a particle 
remains in a system. In biotechnology the common parameter describing this value is the 
reciprocal of the residence time, the dilution rate (D). It is defined as the flow (?̇?) through the 
bioreactor divided by the filling volume (VL): 
𝐷 =  
?̇?
𝑉𝐿
             (6.6) 
Inserting equations 6.5 and 6.6  in equation 6.4 leads to: 
𝑑𝛹
𝑑𝑡
= ∑ .𝛹 + 𝑫 ∙ 𝜳𝑭 − 𝑫 ∙ (𝟏 − 𝑵𝑭) ∙ 𝜳𝑷 − 𝑫 ∙ 𝑵𝑭 ∙ 𝜳𝑵𝑭     (6.7) 
This general expression of equation 6.7 is specified for the RFD relevant variables, namely 
the biomass (X), the two substrates glucose (SGluc) and glutamine (SGlut) as well as the product 
(P) and the two byproducts ammonium (BPA), produced during glutamine conversion, and 
lactate (BPL), produced during glucose conversion, in equations 6.8 – 6.13. 
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For the conversion term of the different variables the following variables, constants and 
parameters are taken into account: the growth and death rate (µ) and (µd), the yields (Y), the 
maintenance coefficients (m), the degradation rate of glutamine into ammonium (dGlut) and the 
removal rate of ammonium due to gas sparging of ammonia (rA). The product formation is 
calculated according to the very general approach of Luedeking-Piret (Luedeking and Piret, 
1959) with the a growth associated constant (α) and a non-growth associated constant (β) for 
product formation as well as the monod constants for glucose and glutamine (kM).  
The flow terms into the bioreactor of equation 6.7 are calculated with the medium supplies 
(Sf). To calculate the flow terms out of the bioreactor a homogenous mixture is assumed. 
Thus, concentrations in the permeate and the non-filtered product stream are equal          
(𝛹𝑃 = 𝛹𝑁𝐹) except for the biomass, which is retained in the bioreactor and only removed 
through the non-filtered product stream (𝑋𝑃 = 0). 
𝑑𝑋
𝑑𝑡
= (µ −  µ𝑑) ∙ 𝑋 − 𝑫 ∙ 𝑿 ∙ 𝑵𝑭         (6.8) 
𝑑𝑆𝐺𝑙𝑢𝑐
𝑑𝑡
= − (
µ− µ𝑑
𝑌𝑋𝑆𝐺𝑙𝑢𝑐
+ 𝑚𝐺𝑙𝑢𝑐) ∙ 𝑋 + 𝑫 ∙ (𝑺𝑭,𝑮𝒍𝒖𝒄 − 𝑺𝑮𝒍𝒖𝒄)     (6.9) 
𝑑𝑆𝐺𝑙𝑢𝑡
𝑑𝑡
= − (
µ− µ𝑑
𝑌𝑋𝑆𝐺𝑙𝑢𝑡
+ 𝑚𝐺𝑙𝑢𝑡) ∙ 𝑋 − 𝑑𝐺𝑙𝑢𝑡 ∙ 𝑆𝐺𝑙𝑢𝑡 + 𝑫 ∙ (𝑺𝑭,𝑮𝒍𝒖𝒕 − 𝑺𝑮𝒍𝒖𝒕)  (6.10) 
𝑑𝐵𝑃𝐿
𝑑𝑡
= (
µ− µ𝑑
𝑌𝑋𝑆𝐺𝑙𝑢𝑐
+ 𝑚𝐺𝑙𝑢𝑐) ∙ 𝑌𝐵𝑃𝐿𝑆𝐺𝑙𝑢𝑐 ∙ 𝑋 − 𝑫 ∙ 𝑩𝑷𝑳      (6.11) 
𝑑𝐵𝑃𝐴
𝑑𝑡
= (
µ− µ𝑑
𝑌𝑋𝑆𝐺𝑙𝑢𝑡
+ 𝑚𝐺𝑙𝑢𝑡) ∙ 𝑌𝐵𝑃𝐴𝑆𝐺𝑙𝑢𝑡 ∙ 𝑋 + 𝑑𝐺𝑙𝑢𝑡 ∙ 𝑆𝐺𝑙𝑢𝑡 + 𝑟𝐴 ∙ 𝑋 − 𝑫 ∙ 𝑩𝑷𝑨  (6.12) 
𝑑𝑃
𝑑𝑡
= (𝛼 ∙
𝑑𝑋
𝑑𝑡
+ 𝛽 ∙ 𝑋) ∙
𝑆𝐺𝑙𝑢𝑐
𝑆𝐺𝑙𝑢𝑐+𝑘𝑀,𝐺𝑙𝑢𝑐
∙
𝑆𝐺𝑙𝑢𝑡
𝑆𝐺𝑙𝑢𝑡+𝑘𝑀,𝐺𝑙𝑢𝑡
− 𝑫 ∙ 𝑷     (6.13) 
The non-bolt parts of the mass balances (Equation 6.8 – 6.13) represent the conversion term 
and, thus, are valid for batch cultures and RFD. The bolt parts of the equations describe the 
flow in and out of the bioreactor and, therefore, are only used in the RFD model. 
Furthermore, constitutive equations for the growth and death rate of biomass as well as the 
maintenance of glutamine are implemented in the model based on the model of Xing et al. 
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(2010). Cell death is accelerated at increased lactate or ammonium concentrations. Thus, 
terms for the two byproducts are used for calculating the death rate. Also, the maximum 
growth rate (µmax), the death constant (kd) and two constant (α1) and (α2) are considered: 
µ =  µ𝑚𝑎𝑥 ∙
𝑆𝐺𝑙𝑢𝑐
𝑆𝐺𝑙𝑢𝑐+𝑘𝑀,𝐺𝑙𝑢𝑐
∙
𝑆𝐺𝑙𝑢𝑡
𝑆𝐺𝑙𝑢𝑡+𝑘𝑀,𝐺𝑙𝑢𝑡
∙
𝑘𝑀,𝐿
𝐵𝑃𝐿+𝑘𝑀,𝐿
∙
𝑘𝑀,𝐴
𝐵𝑃𝐴+𝑘𝑀,𝐴
     (6.14) 
 
µ𝑑 =  𝑘𝑑 ∙
𝐵𝑃𝐿
𝐵𝑃𝐿+𝑘𝑑,𝐿
∙
𝐵𝑃𝐴
𝐵𝑃𝐴+𝑘𝑑,𝐴
          (6.15) 
𝑚𝐺𝑙𝑢𝑡 =  
𝛼1∙𝑆𝐺𝑙𝑢𝑡
𝛼2+𝑆𝐺𝑙𝑢𝑡
           (6.16) 
Constants are determined from batch data obtained in chapter 5.2.2 and listed in Table 6-1, 
parameters are estimated as shown in chapter 6.2. To simulate the lag phase of the culture 
µmax was substituted by µmax,S for the first 36 h. 
 
Table 6-1: CHO specific constants obtained from a batch culture. 
Constant Value Unit Note 
µ𝒎𝒂𝒙,𝒔 0.0029 h
-1
 0 – 36 hours to simulate lag phasea 
µ𝒎𝒂𝒙 0.028 h
-1
 36 – 96 hours for exponential phasea 
𝒌𝒅 0.0070 h
-1
 387 – 430 hours for death phaseb 
𝒀𝑿𝑺𝑮𝒍𝒖𝒄  1.23 10
6
 cells mL
-1
 mg
-1
 36 – 172 hoursb 
𝒀𝑿𝑺𝑮𝒍𝒖𝒕  5.55 10
6
 cells mL
-1
 mg
-1
 36 – 172 hoursb 
𝒀𝑩𝑷𝑳𝑺𝑮𝒍𝒖𝒄  0.47 g g
-1
 36 – 172 hours 
𝒀𝑩𝑷𝑨𝑺𝑮𝒍𝒖𝒕  0.095 g g
-1
 36 – 172 hours 
a
Biomass data obtain from capacity signal 
b
Biomass data obtain by CASY measurement 
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6.2 Parameter estimation for CHO DG44 cells 
In contrast to the CHO specific constants (Table 6-1), parameters cannot directly be 
determined from batch data. Therefore, a parameter estimation using a Monte Carlo 
simulation (Metropolis and Ulam, 1949) was conducted. In general, a Monte Carlo simulation 
is a stochastically method to obtain numerical results by repeated random simulations. In this 
study, repeated simulations were conducted with one million parameter sets, consisting of 
eleven parameters. Each parameter set was randomly generated to achieve a statistically 
distribution of possible values for the unknown parameter sets. 
 
Randomly chosen parameters (𝜃) of the parameter set were generated independently within a 
given reasonable physical space (pmin and pmax given in Table 6-2) and a random number (r) 
between 0 and 1. Within this study, the following algorithm was used: 
𝜃 = 𝑝𝑚𝑖𝑛 + (𝑝𝑚𝑎𝑥 − 𝑝𝑚𝑖𝑛) ∙ 𝑟         (6.17) 
 
A simulation based on the model developed in chapter 6.1 was conducted with each of the one 
million generated parameter sets. The simulation was performed in Matlab with “ODE45” as 
solver for differential equations. The parameter set (𝜃𝑖,𝑠𝑖𝑚) with the best fitting to the batch 
data (𝜃𝑖,𝑒𝑥𝑝) was determined by the smallest sum square error (min SSE): 
𝑚𝑖𝑛𝑆𝑆𝐸 =  ∑ (𝜃𝑖,𝑒𝑥𝑝 − 𝜃𝑖,𝑠𝑖𝑚)
2𝑛
𝑖=1          (6.18) 
The best parameter set was further adapted to the batch data with the Matlab optimizer 
function “fminsearch”. This function examines the neighborhood of each parameter with the 
aim to minimize the sum square error. The result of the parameter estimation is displayed in 
Table 6-3. 
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Table 6-2: CHO specific parameter space for parameter estimation. 
Constant Unit pmin pmax 
𝒎𝑮𝒍𝒖𝒄 10
-12
 mg L cells
-1
 h
-1
 0.09 54 
𝒌𝑴,𝑮𝒍𝒖𝒄 g L
-1
 1.8·10
-5
 0.18 
𝒌𝑴,𝑮𝒍𝒖𝒕 g L
-1
 1.5·10
-5
 0.15 
𝒌𝑴,𝑳 g L
-1
 0.09 9 
𝒌𝑴,𝑨 g L
-1
 0.009 0.36 
𝒌𝒅,𝑳 g L
-1
 0.09 9 
𝒌𝒅,𝑨 g L
-1
 0.009 0.36 
𝜶 10-12 L cells-1 h-1 0.001 5 
𝜷 10-12 L cells-1 h-2 0.001 5 
𝜶𝟏 10
-12
 mg L cells
-1
 h
-1
 0.073 43.8 
𝜶𝟐 g L
-1
 0.073 2.92 
rA 10
-12
 mg L cells
-1
 h
-1
 0.55 1000 
dGlut h
-1
 0.001 0.01 
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Table 6-3: CHO specific estimated parameter using the Monte Carlo method with a parameter 
set of one million. 
Constant Unit Value Literature (Xing et al., 
2010) 
𝒎𝑮𝒍𝒖𝒄 10
-12
 mg L cells
-1
 h
-1
 7.74 0 – 36000  
𝒌𝑴,𝑮𝒍𝒖𝒄 g L
-1
 0.15 0.027 – 0.18 
𝒌𝑴,𝑮𝒍𝒖𝒕 g L
-1
 0.073 0.0088 – 0.12 
𝒌𝑴,𝑳 g L
-1
 0.47 0.72 –12.60  
𝒌𝑴,𝑨 g L
-1
 0.31 0.018 – 0.36 
𝒌𝒅,𝑳 g L
-1
 2.16 1.35 – 27.99  
𝒌𝒅,𝑨 g L
-1
 0.046 0.026 – 0.081 
𝜶 10-12 L cells-1 h-1 2.07 n.a. 
𝜷 10-12 L cells-1 h-2 0.49 n.a. 
𝜶𝟏 10
-12
 mg L cells
-1
 h
-1
 2.336 0 – 49640 
𝜶𝟐 g L
-1
 2.628 0.029 – 0.58 
rA 10
-12
 mg L cells
-1
 h
-1
 350 n.a. 
dGlut h
-1
 0.0072 n.a. 
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6.3 Simulation of experimental data 
A simulation of the batch model of chapter 6.1 with the constants determined in the same 
chapter and the parameters estimated in chapter 6.2 is shown in Figure 6-2 as black line. Blue 
dots in Figure 6-2 display the batch data the simulation is based on. The viable cell density as 
well as the glucose and product concentrations are fitted accurately with a coefficient of 
determination R
2
 > 0.9. As these values are measured with three different analytical assays 
with respective analytical errors the reliability of model fit can be regarded as very high. The 
progress of glutamine, lactate and ammonium is represented adequately with the model. 
However, during the whole cultivation time glutamine and lactate are over- and 
underestimated, respectively. For ammonium it should be noted that the first measured data 
points are underestimated as the analytical device is not sensitive enough.   
Simulation of the perfusion conducted in chapter 5.2.3 is shown in Figure 6-3. Events were 
implemented in the Matlab code as they occurred: A switch from batch phase to perfusion at 
D = 0.5 d
-1
 at t = 114 h, drop out of pumps at t = 170 h for 3 h, switch of perfusion rate to 
D = 1 d
-1
 at 216 h, another drop out of pumps at t = 242 h for 8 h and finally, switch of 
perfusion rate to D = 2 d
-1
 at t = 360 h. As membrane fouling occurred at the highest dilution 
rate, the non-filtered ratio (NF) decreased. This decrease of NF was also considered in the 
model.  
The progress of the simulated data and the measured data are in good accordance. The viable 
cell density, the concentration of product as well as of the two substrates glucose and 
glutamine can be simulated sufficiently. The concentration of lactate is underestimated as it 
was in the batch. Again the concentration of ammonium was not detected sufficiently in the 
perfusion culture. Hence, a statement about the accuracy of the fit of ammonium is not 
possible at this time.  
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Figure 6-2: Simulation (black line) of a batch fermentation of CHO DG44 cells. Simulation 
was conducted with Matlab, differential equations were solved with the solver ODE45, and 
constants were taken from the batch data. Parameters were estimated using the Monte Carlo 
method based on one million randomly generated parameter sets consisting of eleven 
parameters. Batch data (open circles) was taken from experiments described in chapter 5.2.2.  
 
It is remarkable that the simulation is based on constants and parameters fitted to solely one 
batch experiment. The accuracy of the simulation can be improved if the values of the 
parameters and constants would be an average of more batch experiments. Furthermore, 
within the perfusion experiment two drop out of the pumps occurred, which also influences 
the result. Hence, a sound perfusion experiment should be conducted to evaluate the real 
potential of the simulation. Despite the two mentioned drawbacks, the simulation of the 
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perfusion is satisfactory. Thus, the simulation was used to predict the optimal dilution rate in 
terms of productivity.  
 
 
Figure 6-3: Simulation (black line) of the perfusion of CHO DG44 cells applying RFD (open 
circles) conducted in chapter 5.2.3. Simulation was conducted with matlab, differential 
equations were solved with the solver ODE45, and constants were taken from the batch data. 
Parameters were estimated using the Monte Carlo method based on one million randomly 
generated parameter sets consisting of eleven parameters and fitted to batch data. Batch and 
perfusion data were taken from chapter 5.2.2 and 5.2.3, respectively. 
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6.4 Optimized operation conditions for CHO DG 44 
In chapters 4 and 5 RFD was optimized regarding the experimental set-up, biocompatibility, 
long-term stability, minimal membrane area and maximum product recovery. Hence, an 
optimization of process parameters to improve the productivity of the mammalian cell culture 
is the next optimization step.  
Experiments with CHO cells conducted in chapter 5.2 were used as proof of concept to 
demonstrate the compatibility of RFD with CHO cells. Three distinct dilution rates of 
D = 0.5 d
-1
, 1 d
-1
 and 2 d
-1
 as well as a non-filtered ratio of NF = 0.1 were applied based on 
the critical flux and data provided by Tanja Holland (Fraunhofer IME, Aachen, Germany). An 
experimental optimization of these parameters was not conducted as this would have been 
costly in terms of time and money. In contrast, optimized parameters by means of the model 
developed in chapter 6.1 can be received fast and favorable.  
The accumulated product concentration for the experiment conducted in chapter 5.2.3 with 
and without disturbances is depicted in Figure 6-4. Furthermore, a simulation of a perfusion 
culture applying RFD is conducted, where the perfusion rate is increased by D = 0.5 d
-1
 every 
time a glucose concentration of 4 g L
-1
 is reached. Thus, a nearly constant cell concentration 
is achieved without depletion of the C-source. This strategy is called cell specific perfusion 
rate (CSPR) and often used for perfusion cultures (Clincke et al., 2013a; Dowd et al., 2003; 
Ozturk, 1996). CSPR could not be followed in the perfusion experiment of chapter 5.2.3 as 
glucose could not be detected online. The accumulated product concentration of a RFD 
simulation following the CSPR perfusion strategy is also shown in Figure 6-4. 
According to the simulation results of Figure 6-4 the accumulated product concentration for 
the perfusion experiment conducted in chapter 5.2.3 would have been approximately three 
times as high if no disturbances would have occurred. A further increase from 4095 mg L
-1
 
accumulated product in the non-filtered stream to 4894 mg L
-1
 can be achieved if the 
fermentation strategy is adapted to CSPR.    
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Figure 6-4: Accumulated product concentration for perfusion cultures of CHO DG44 cells 
applying RFD. D was varied according to the perfusion experiment in chapter 5.2.3 or 
according to the strategy of CSPR. One perfusion culture was simulated with the disturbances 
which occurred in the respective experiment. Simulation was conducted with Matlab, 
differential equations were solved with the solver ODE45, and constants were taken from the 
batch data (chapter 5.2.2.). Parameters were estimated using the Monte Carlo method based 
on a parameter set of one million randomly generated parameters and fitted to batch data. 
 
The developed model and the parameter estimation conducted in this chapter enable the 
prediction of perfusion experiments. Optimized setting of non-filtered ratio and dilution rates 
for higher accumulated product concentration can be chosen based on the predication saving 
experimental time and costs. However, the experimental proof of the simulation results was 
not conducted yet. Furthermore, the optimization was conducted exemplarily for one 
perfusion strategy. Thus, the optimization potential of the model is not tapped. Other 
optimization strategies with e.g. varying non-filtered ratios during one perfusion experiment 
can be conducted to enhance the accumulated product concentration further. In addition, the 
simulation can be used to forecast the impact of disturbances during a perfusion experiment or 
to improve the feed composition. 
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Chapter 7 
7Quasi-continuous Operation of a Reverse-flow 
Diafiltration Membrane Bioreactor 
In this chapter, the improvement of conventional RFD by realizing a quasi-continuous RFD is 
shown. In conventional RFD the feeding is pulsed, which can cause short-term oxygen 
limitations and the formation of overflowmetabolites. By sequential operation of three 
membranes in quasi-continuous RFD feed pulses are avoided. Thus, constant concentration 
profiles are achieved in the bioreactor. In the first part of this chapter, the pulsed feeding of 
conventional RFD and its impact on the yeast H. polymorpha is investigated. In particular, 
fermentation conditions which result in repeated short-term oxygen limitations due to pulsed 
feeding were examined and compared to oxygen unlimited conditions. In the second part, a 
process scheme for sequential operation of three membranes is introduced. Finally, the 
sequential operation is experimentally investigated for several dilution and stirring rates. 
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7.1 Conventional Operation of a Reverse-flow Diafiltration 
at Two Distinct Dilution Rates 
Reverse-flow diafiltration alternates harvesting and feeding over the same membrane, 
resulting in a continuous C-source limited culture with a pulsed feeding mode. RFD was 
applied at D = 0.1 h
-1
 and D = 0.2 h
-1
 to examine the impact of RFD or rather pulsed feeding 
on the oxygen supply. As the working volume of the bioreactor was 1.5 L, a homogenous 
distribution of substrate concentrations such as oxygen or glucose was expected. Hence, the 
obtained values are representative for the entire bioreactor volume. Figure 7-1 depicts the 
dissolved oxygen tension (DOT) and the applied stirring rate for the two examined dilution 
rates. Pulsed feeding of glucose causes an oscillation of the DOT signal as the consumption of 
glucose and dissolved oxygen is coupled to each other. Whereas the DOT signal oscillates 
between 25 and 31% and, therewith, has an amplitude of approximately 3% for a dilution rate 
of D = 0.1 h
-1
, the oscillation amplitude increases to 30% at a dilution rate of D = 0.2 h
-1
. In 
the transition of the dilution rates an excessive amount of glucose reduces the oscillation and 
the stirring rate is raised until the culture is glucose limited and oscillation of the DOT signal 
starts again. The average DOT signal for both dilution rates is approximately 30%, which 
corresponds to the DOT set point of 30% maintained by the stirring rate. However, the 
minimal DOT signal for the dilution rate of 0.2 h
-1
 is below 10%, which may trigger 
suboptimal oxygen supply. Whereas a higher DOT set point or a manual adjustment of the 
stirring rate can both solve this problem for D = 0.2 h
-1
, the effort to guarantee a sufficient 
oxygen supply increases with increasing dilution rates as the oscillation amplitude increases 
as well.  
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Figure 7-1: Dissolved oxygen tension and stirring rate of a continuous fermentation of 
Hansenula polymorpha pCoM11sc3625 with reverse-flow diafiltration at two dilution rates; 
all three membranes are operated in parallel. DOT set-point of 30% was maintained by 
adjusting the stirring rate. Culture conditions: synthetic medium Syn-6, 20 g L
-1
 glucose, 
VL = 1.5 L, q = 1 vvm, pH value of 5.5, T = 37 °C, 3 MF02 membranes with a length of 1 m 
each, aE = 1.8, aF = 0.7, NF = 0.5.  
 
 
7.2 Short Term Oxygen Limitation by Pulsed Feeding 
As shown in chapter 7.1, pulsed feeding causes an oscillation of the DOT signal. The higher 
the dilution rate and, therewith, the amount of glucose fed, the higher the consumption of 
dissolved oxygen. As a consequence, the oscillation of the DOT signal increases as well. The 
options to elevate the minimal DOT signal such as increasing stirring rate or aeration rate are 
limited. Therefore, short-term oxygen limitations cannot be avoided at high dilution rates 
under feasible fermentation conditions. Thus, the impact of short-term oxygen limitation due 
to pulsed feeding is examined at a dilution rate of 0.2 h
-1
 using RFD.  
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Oxygen unlimited fermentation conditions and short-term oxygen limited fermentation 
conditions caused by a reduction of the stirring rate from 1200 rpm to 1100 rpm are compared 
in Figure 7-2. The oscillation amplitude of the DOT signal is approximately 30% under 
oxygen unlimited fermentation conditions at a stirring rate of 1200 rpm or 25% under short-
term oxygen limited fermentation conditions at a stirring rate of 1100 rpm, respectively 
(Figure 7-2 A). The oxygen transfer rate (OTR) signal oscillates with the same frequency as 
the DOT signal with an amplitude of 30 mmol L
-1
 h
-1
 under oxygen unlimited fermentation 
conditions or 20 mmol L
-1
 h
-1
 under short-term oxygen limited fermentation conditions, 
respectively (Figure 7-2 B). The respiratory quotient (RQ) is approximately 1.0 under oxygen 
unlimited fermentation conditions indicating oxidative growth on glucose. Under short-term 
oxygen limited fermentation conditions the RQ reaches values of around 1.5 implying the 
formation of overflow metabolites. 
The formation of overflow metabolites is also evident by HPLC measurements (Figure 
7-2 C). Ethanol could not be detected under oxygen unlimited fermentation conditions, 
whereas under short-term oxygen limited fermentation conditions its concentration increases 
to 1.6 g L
-1
. Furthermore, short-term oxygen limited fermentation conditions lead to a 
decrease of 25% of the secreted protein concentration, a single-chain antibody. The 
concentration of the antibody was approximately 0.2 g L
-1
 under oxygen unlimited and 
0.15 g L
-1
 under oxygen short-term limited conditions. It is known that the biomass yield 
decrease under oxygen limiting fermentation conditions (Enfors et al., 2001). However, the 
dry cell weight is not notably affected by the examined short-term oxygen limitation and 
remains at approximately 19 g L
-1
 for both conditions. The concentration of glucose remains 
undetectable for both settings. 
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Figure 7-2: Continuous fermentation of Hansenula polymorpha pCoM11sc3625 with reverse-
flow diafiltration at oxygen unlimited and short-term limited conditions caused by different 
stirring rates; all three membranes are operated in parallel. Stirring rate was adjusted 
manually; DOT set-point was not maintained. Culture conditions: synthetic medium Syn-6, 
20 g L
-1
 glucose, VL = 1.5 L,  q = 1 vvm, pH value of 5.5, T = 37 °C, 3 MF02 membranes with 
1 m length each, aE = 1.8, aF = 0.7, NF = 0.5, D = 0.2 h
-1
 A) Dissolved oxygen tension (DOT) 
and stirring rate. B) Oxygen transfer rate (OTR) as well as respiratory quotient (RQ). C) Dry 
cell weight (DCW), antibody, ethanol and glucose concentration. 
 
Quasi-continuous Operation in Reverse-flow Diafiltration Bioreactor 106 
  
 
 
Figure 7-3: True to scale time dependent liquid flow of reverse-flow diafiltration and the 
resulting dissolved oxygen tension at different stirring rates for a continuous fermentation of 
Hansenula polymorpha pCoM11sc3625 at a dilution rate of D = 0.2 h
-1
; all three membranes 
are operated in parallel. Culture conditions: synthetic medium Syn-6, 20 g L
-1
 glucose, 
VL = 1.5 L, q = 1 vvm, pH value of 5.5, T = 37 °C, 3 MF02 Membranes a 1 m aE = 1.8, 
aF = 0.7, NF = 0.5. A) True to scale time dependent liquid flow B) Dissolved oxygen tension 
(DOT), not oxygen limited C) Dissolved oxygen tension (DOT), oxygen limited. 
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A magnification of the DOT signal under oxygen unlimited and short-term oxygen limited 
fermentation conditions is compared in Figure 7-3 for the reverse-flow diafiltration mode 
using all three membranes in parallel. The examined time span is plotted relative to each other 
to synchronize the reverse-flow diafiltration sequences in all diagrams of Figure 7-3. The step 
sequence starts with feeding into the membrane bioreactor. Simultaneously, a sharp decrease 
of the DOT signal can be noticed as long as feeding is proceeded. The DOT signal remains at 
the lower level for a few seconds before it rises to the higher level until feeding starts again. 
Whereas under oxygen unlimited fermentation conditions at a stirring rate of 1100 rpm the 
DOT signal reaches a minimum of approximately 10% for a few seconds (Figure 7-3 B), the 
DOT signal remains close to zero for a short period of time indicating the oxygen limitation 
(Figure 7-3 C). The simultaneous behavior of the DOT signal of both fermentation conditions 
in correlation with the flow generated by the RF in Figure 7-3 proofs that the pulsed feeding is 
the main reason for the oscillating DOT signal. 
Beside the pulsed feeding, the other three steps of RFD (flushing, emptying and permeate) or 
the feeding through the membrane could contribute to the oscillating DOT signal as these 
properties are unique in RFD and not applied in conventional continuous cultures. To verify 
that pulsed feeding is the main cause of the oscillating DOT signal, an experiment with pulsed 
feeding was performed in the bioreactor without membranes (see also Figure 2-6, set up with 
dashed-dotted line and dotted line). To achieve comparable fermentation conditions, the 
feeding frequency and duration was adjusted according to the RFD experiments. Thus, 180 s 
of feeding alternated with 360 s of feeding stop (compare also Table 2-4). All other 
fermentation parameters were kept as in the previous experiment including the setting of the 
stirring rate of 1200 rpm and 1100 rpm (compare Figure 7-2).  
Figure 7-4 depicts the obtained data. The DOT signal oscillates between 10 and 70% or 0 and 
50% under oxygen unlimited fermentation conditions or short-term oxygen limited 
fermentation conditions, respectively (Figure 7-4 A). In this experiment, the oscillation of the 
DOT signal is more uniform than in the experiment with RFD (compare Figure 7-2 A and 
Figure 7-4 A). This may be caused by the medium provided through the membrane. In the 
membrane concentration gradients may occur due to RFD mode in contrast to pulsed feeding 
via a feed inlet. However, the frequency and the average DOT signals in both experiments are 
comparable. Also, data from the exhaust gas analysis – OTR and RQ –  are  similar  regarding  
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Figure 7-4: Continuous fermentation of Hansenula polymorpha pCoM11sc3625 without 
membranes applying pulsed feeding at different stirring rates: 180 s of feeding alternates with 
360 s of feeding stop. Stirring rate was adjusted manually; DOT set-point was not maintained. 
Culture conditions: synthetic medium Syn-6, 20 g L
-1
 glucose, VL = 1.5 L, q = 1 vvm, 
pH value of 5.5, T = 37 °C, D = 0.2 h
-1
. A) Dissolved oxygen tension (DOT) and stirring rate. 
B) Oxygen transfer rate (OTR) as well as respiratory quotient (RQ). C) Dry cell weight 
(DCW), antibody, ethanol and glucose concentration. 
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the measured values as well as glucose and ethanol concentrations. The amount of dry cell 
weight is 10 g L
-1
, which is half of the concentrations detected in the experiment with RFD. 
As cell retention in RFD was set to 50% this value was expected for an experiment without 
membranes. Furthermore, the absolute level of antibody concentration is decreased in the 
experiment without membrane (Figure 7-4) in comparison to the experiment with RFD 
(Figure 7-2). This can also be explained by the absence of cell retention (Meier et al., 2014). 
However, deviations regarding DOT, OTR, RQ, glucose and ethanol concentrations in Figure 
7-2 and 6-4 could not be noticed. Hence, the pulsed feeding of glucose can be regarded as the 
main reason for an oscillating DOT signal during RFD operation. 
A decrease of the product concentration has to be prevented as antibodies are high-value 
products. Thus, pulsed feeding in RFD has to be avoided.  
 
 
7.3 Sequential Operation of Membranes in Reverse-flow 
Diafiltration 
RFD alternates harvest and feeding causing an oscillation of DOT signal. A more uniform 
feeding by reducing the step times of the non-feeding steps – permeate, emptying and flushing 
– cannot be conducted without a loss of efficiency. Therefore, three membranes arranged in 
parallel operating sequentially were used to provide a uniform feed supply into the membrane 
bioreactor.  
A true to scale representation of the time dependent flows in and out of the bioreactor for the 
sequential operation mode is shown in Figure 7-5. At the left hand side the liquid flows for 
the single membranes ( - ) are depicted, operated at their particular time sequences. Each 
sequence is time-shifted by 180 s as this is the feed step time. Summing up the flows of the 
three membranes results in an overall flow illustrated at the top right hand side. The flow into  
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the bioreactor is continuous as the three membranes seamlessly alternate in their feeding 
action. Also the non-filtered product stream is purged continuously as the pump control is too  
slow to respond to the small volume changes due to RFD mode. Only the flushing, emptying 
and permeate step affect the overall permeate output resulting in a step pattern. Hence, the 
fermenter volume merely varies slightly, which is often observed in cell retention systems 
(Clincke et al., 2013a; Tang et al., 2007). The average permeate output is depicted as a dotted 
line in the true to scale representation of the overall flows in Figure 7-5. A permeate output 
slightly below the average indicates that one membrane is operated in the permeate step and 
one membrane is conducting the emptying step (compare start of the cycle in  Figure 7-5: 
membranes no. 2  and 3 at left hand side as well as overall permeate output at right hand side). 
Followed by this step combination, two membranes are operated in the permeate step 
resulting in a permeate output above the average. Afterwards one of the membranes is flushed 
causing the lowest permeate output. After all four steps were conducted by every membrane, 
one cycle is completed. The step sequence and the step times for a cycle of three membranes 
operated sequentially are shown in a tabular form in Figure 7-5. 
Settings of the feed and the permeate pumps for the four steps of RFD are given in Table 2-5 
depending on the dilution rate. For instance, at the beginning of a cycle membrane 1 is 
operated in the feed step, membrane 2 in the permeate step and membrane 3 in the emptying 
step (compare Figure 7-5). If a dilution rate of 0.1 h
-1
 should be applied, the feed pump of 
membrane 1 generates a flow rate of 29.3 L m
-2
 h
-1
 whereas the permeate pump of membrane 
1 stops (feed step). Simultaneously, the feed pump of membrane 2 stops while the permeate 
pump generates a flow rate of 6.0 L m
-2
 h
-1
 (permeate step). At the same time the feed and the 
permeate pump of membrane 3 operates with a flow rate of 50 L m
-2
 h
-1
 and 10 L m
-2
 h
-1
 into 
the direction of the feed tank, respectively (emptying step). 
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Figure 7-5: True to scale representation of time dependent flow into and out of the reactor of 
three membranes operated sequentially in the reverse-flow diafiltration mode ( -  left 
hand side) and the resulting overall feed, permeate and non-filtered product stream flow (right 
hand side) for a cell retention of 50%. The average permeate output is represented by a dotted 
line. It should be noted that the integral of the flows pumped in and out of the bioreactor 
equals zero in every cycle. The non-filtered product stream is 50% of the overall feed, equal 
to Figure 2-5. Relative heights of feed and non-filtered product stream differ in comparison to 
Figure 2-5 as the overall feed is split into three membranes operated sequentially. 
Furthermore, steps and step times for the sequential operation of all three membranes are 
stated in the Table. 
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7.4 Preventing Oxygen Limitation by Sequential Operation 
The implementation of sequential operation for a dilution rate of 0.2 h
-1
 is illustrated in Figure 
7-6. For better comparison, the same fermentation conditions as in Figure 7-2 were applied, 
except for the sequential feeding. The DOT signal oscillates around 45 – 55% and 35 - 45% 
for a stirring rate of 1200 rpm and 1100 rpm, respectively (Figure 7-6 A). Although the 
oscillation of the DOT signal cannot be completely prevented as in common continuous 
fermentations, a significant reduction of the amplitude of the oscillation could be observed. 
The small oscillation could be caused by the mixture of feed and permeate present in the feed 
tubing at the beginning of the feed step. Thus, a lower glucose concentration is pumped into 
the bioreactor for a short period of time, every time the membrane feeding operation is 
sequentially changed. Another explanation for the small oscillation of the DOT signal could 
be differences in the feed flow of the three manually calibrated feed pumps. However, 
sequential feeding strongly reduces the oscillation. Thus, fermentation conditions are more 
constant and oxygen limitation could be completely avoided. 
The OTR and RQ signals are slightly oscillating for both stirrer settings (Figure 7-6 B), 
though the RQ remains around 1.0 indicating oxidative growth on glucose. This observation is 
verified by the measurement of metabolites (Figure 7-6 C). Neither glucose nor ethanol could 
be detected for the chosen stirrer settings. The concentration of antibodies and the dry cell 
weight remain constant for both settings. Thus, the oxygen supply at a stirring rate of 
1100 rpm is not sufficient for membranes operated in parallel to avoid short-term oxygen 
limitations (Figure 7-2), but completely sufficient for membranes operated sequentially.  
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Figure 7-6: Continuous fermentation of Hansenula polymorpha pCoM11sc3625 with reverse-
flow diafiltration at different stirring rates; three membranes are operated sequentially. 
Culture conditions: synthetic medium Syn-6, 20 g L
-1
 glucose, VL = 1.5 L, q = 1 vvm, 
pH value of 5.5, T = 37 °C, 3 MF02 Membranes a 1 m, aE = 1.8, aF = 0.7, NF = 0.5, tC = 510s, 
D = 0.2 h
-1
 A) Dissolved oxygen tension (DOT) and stirring rate. B) Oxygen transfer rate 
(OTR) as well as respiratory quotient (RQ). C) Dry cell weight (DCW), antibody, ethanol and 
glucose concentration. 
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7.5 Sequential Operation at Several Distinct Dilution Rates 
The effect of an oscillating DOT signal due to pulsed feeding by membranes operated in 
parallel increases with increasing dilution rates. Hence, the sequential feeding was examined 
for dilution rates in the range of 0.1 h
-1
 to 0.5 h
-1
. The results are depicted in Figure 7-7. As 
already observed in the last chapter for a dilution rate of 0.2 h
-1
, small oscillations of the DOT 
signal occur with sequential operation of the membranes for the applied dilution rates (Figure 
7-7 A). Sequential feeding at a dilution rate of 0.5 h
-1
 causes the biggest oscillations in the 
range of 20 to 60%. Nevertheless, the oscillations for this dilution rate are smaller than the 
oscillations of membranes operated in parallel at a dilution rate of 0.2 h
-1
 (Figure 7-2 A). 
Whereas a stirring rate of 1200 rpm was necessary to provide a sufficient oxygen supply for 
membranes operated in parallel (Figure 7-2 A), this rate could be reduced to 900 rpm if 
membranes are operated sequentially saving energy and reducing cell damage. Sufficient 
oxygen supply for all dilution rates is also indicated by the OTR and RQ (Figure 7-7 B). The 
RQ for all applied dilution rates is around 1.0 implying oxidative growth on glucose. This 
conclusion is confirmed by measurement of metabolites as neither ethanol nor glucose could 
be detected (Figure 7-7 C). The dry cell weight remains constant for all applied dilution rates. 
The concentration of antibodies decreases at higher dilution rates. This effect is caused by the 
formation of a minimal fouling layer and was observed before in chapter 5.1.2. Sequential 
feeding proves to minimize oscillations of the DOT signal. Thus, higher dilution rates can be 
applied at lower stirring or aeration rates to supply sufficient oxygen saving energy and 
reducing cell damage. 
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Figure 7-7: Continuous fermentation of Hansenula polymorpha pCoM11sc3625 with reverse-
flow diafiltration at different dilution rates; three membranes are operated sequentially. 
Culture conditions: synthetic medium Syn-6, 20 g L
-1
 glucose, VL = 1.5 L, q = 1 vvm, 
pH value of 5.5, T = 37 °C, 3 MF02 Membranes a 1 m, aE = 1.8, aF = 0.7, NF = 0.5, tC = 510s, 
D = 0.2 h
-1
 A) Dissolved oxygen tension (DOT) and stirring rate. B) Oxygen transfer rate 
(OTR) as well as respiratory quotient (RQ). C) Dry cell weight (DCW), antibody, ethanol and 
glucose concentration. 
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Chapter 8 
8Conclusion and Outlook 
The aim of this thesis was the enhancement and establishment of Reverse-flow diafiltration 
(RFD), an in situ product recovery process. In RFD medium supply alternates with product 
recovery over the same submerged hollow fiber membrane. Thus, cells are retained gently 
while simultaneously a potential fouling layer is minimized. The requirements for this process 
were expressed in the project MoBiDiK “Modulare Bioproduktion – Disposable und 
Kontinuierlich”: 
  
 Biocompatible 
 Sterile 
 Robust 
 Long-term stable 
 Continuous high cell retention 
 High antibody transmission 
 Producible as single-use system  
 
Non-biocompatible additives from polymer materials may leach out in the culture medium 
especially during heat sterilization or in presence of solvents and inhibit metabolic activity. 
Thus, it is crucial to precisely understand this leaching behavior. This thesis has shown the 
Respiration Activity MOnitoring System (RAMOS) to be an easy to apply and very sensitive 
device to qualify materials before their application in culture systems. Being fast, reliable and 
cost-effective, the RAMOS device can prevent the use of detrimental polymers, whose 
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plasticizers might leach out and retard the growth of microorganism. This online technique 
ultimately precludes the need for multiple sampling and may be used to determine a metabolic 
activity inhibition threshold of leaching from polymer materials.  
Heat sterilization accelerates leaching of polymer additives. Since biotechnical processes may 
require heat sterilization, it is relevant to include this kind of pretreatment for the evaluation 
of leaching. Otherwise, if e.g. gamma-sterilization is applied (with no need for heat-
sterilization), the polymer material under investigation could be placed in the culture medium 
for a time span corresponding to an average culture time at culture temperature. Thus, 
application conditions are mimicked with this test. A culture with this medium could 
afterwards be monitored by RAMOS to identify the influence of compounds which have 
potentially leached out of the polymer. 
This work and other investigations in literature prove that plasticizers leach out from polymer 
materials. Some plasticizers are toxic to human, animals, mammalian cells and, as shown 
here, to microorganisms. Therefore, the processing as well as the amount of these kinds of 
plasticizers and other harmful additives should be considered and tested by the producers as 
well as the manufactures of polymer materials. In this thesis a biocompatibility test was 
conducted for all applied polymers with the respective organism prior application. 
 
RFD consists of four subsequent steps: feed, emptying, permeate and flushing. The optimal 
emptying and flushing steps prevented mixing of permeate with medium and increase the 
permeate output. Based on calculations of fluid flows the four steps were configured with 
respect to pump settings and step times. The flow of the feed and permeate steps as well as the 
number of applied membranes are calculated as a function of the applied dilution rate. The 
results of the configuration are formulas to calculate the pump settings for the single steps and 
the resulting step times, which are summarized in Table 4-1. This table was the basis for all 
settings applied in biological experiments within this thesis. 
A critical transmembrane pressure increase of 45 Pa min
-1
 should not be exceeded by the 
chosen membrane-medium-culture system to maintain stable filtration properties. The critical 
specific flow rate over the membrane for yeast and CHO cultures applying RFD were 
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determined as 21 L m
-2
 h
-1
 and 9 L m
-2
 h
-1
, resulting in a maximum applicable dilution rate of 
approximately D = 0.7 h
-1
 and D = 1 d
-1
 for stable long-term applications, respectively. The 
resulting necessary filtration area for RFD is smaller than most conventional available 
retention systems. Systems with less filtration area were reported to tend to irreversible 
fouling.  
 
Alternating substrate and product streams results in a feed pulse instead of a continuous 
feeding, causing oscillations of the dissolved oxygen tension. The amplitude of the oscillation 
increases with increasing dilution rate. Hence, also the effort to guarantee a sufficient oxygen 
supply increases e.g. increasing the stirring and / or aeration rate. Short-term oxygen 
limitations cause the formation of overflow metabolites like ethanol as it was shown in this 
study for H. polymorpha. Furthermore, the product concentration decreases during short-term 
oxygen limitation. 
In this thesis, a quasi-continuous feeding was achieved by sequential operation of three 
membranes. The membranes were operated according to the step sequence of reverse-flow 
diafiltration, but time-shifted by 180 s to generate a continuous flow into the membrane 
bioreactor. Thus, oscillation of the dissolved oxygen tension signal can be minimized. The 
oscillation amplitude, which occurs at a dilution rate of 0.5 h
-1
 for sequential operation, is 
smaller than the amplitude corresponding to a dilution rate of 0.2 h
-1
 for membranes operated 
parallel. Thus, sequential operation results in more constant fermentation conditions than 
parallel operation. This is particularly relevant for microorganisms with a fast aerobic 
metabolism to reduce the effort for a sufficient oxygen supply and avoid a decrease of product 
concentration.  
Oscillations could not be completely prevented due to a mixture of feed and permeate liquid 
pumped into the bioreactor at the beginning of the feed step. A higher flow rate at the 
beginning of the feed step could lead to a constant total amount of glucose pumped into the 
bioreactor and, thus, a steady dissolved oxygen tension.  
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A continuous fermentation of H. polymorpha with 50% cell retention could be conducted with 
dilution rates ranging from 0.1 h
-1
 to 0.65 h
-1
. Dry cell weight concentration and the washout 
point could be doubled. Antibody transmission was constantly between 70 – 80%, which is a 
high value in comparison with data presented in literature. The TMP increase became greater 
with higher dilution rates, but did not exceed the critical value of 45 Pa min
-1
, indicating that a 
stable long-term filtration process was achieved. Space-time-yields were three-times that of a 
continuous fermentation without cell retention due to the higher applicable dilution rates. 
A CHO perfusion culture applying RFD yields high viabilities of over 90% for the whole 
culture time. The antibody transmission was between 40 and 60%, which is a common value 
for filtration of proteins in literature. Presumably, the utilization of membranes which do not 
tend to form a polar layer can enhance this value. The filtration performance of RFD was 
predictable and stable for dilution rates up to D = 1 d
-1
. Thus, RFD proved to be also an in situ 
cell retention device appropriate for cultivation of CHO cells. 
 
Simulations are powerful tools to predict experiments while saving time and costs. Within this 
work, a model for batch and RFD cultivations of CHO DG44 cells was developed. Based on 
the batch data constants and parameters of the cell line were calculated and estimated in 
Matlab, respectively. The batch culture could be simulated with a high accuracy; the perfusion 
culture was simulated satisfying taking into account that solely one batch experiment was the 
basis for the parameter estimation and the calculation of the constants. The simulation of RFD 
was used to optimize the fermentation strategy. The accumulated product concentration of the 
experiment conducted was 1390 mg L
-1
. The same perfusion experiment without disturbances 
would achieve 4095 mg L
-1
 according to the simulation. The perfusion strategy of CSPR 
achieves an accumulated product concentration of 4894 mg L
-1
.  
Simulations with varying dilution rates or non-filtered ratios during one perfusion experiment 
can be conducted to enhance the space-time-yield further. In addition, the simulation can 
forecast the impact of disturbances during a perfusion experiment or used to improve the feed 
composition. Thus, the developed model is an efficient tool for investigations of cultivation 
systems and should be to support experiments.  
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Reverse-flow diafiltration proved to fulfil the requirements stated in MoBiDiK: RFD is a fail-
safe and easy applicable in situ product recovery process with low investment costs and 
minimal equipment requirements. Long-term stable filtration performance and a sufficient 
antibody transmission as well as the possibility to integrate it in single-use bags characterize 
RFD as a convenient process for MoBiDiK especially suitable for shear sensitive cells or 
organism prone to oxygen limitation.  
 
 
Figure 8-1: Ideal and reduced permeate output due to pressure loss for yeast and CHO cells. 
Permeate output was calculated based on the critical transmembrane flux of 21 L m
-2
 h
-1
 or 9 
L m
-2
 h
-1
 for H. polymorpha or CHO cells, respectively. Settings of RFD: aE = 1.69, aF = 0.7, 
tC = 510s and NF = 0.5 or 0.9 for H. polymorpha or CHO cells, respectively. 
 
To realize an industrial application of RFD for CHO cells, an up scaling to a fermenter 
volume of 10 L should be conducted. In comparison to the experiments conducted in 1 L scale 
in this thesis, a 10-fold membrane area should be applied. Thus, applying the same 
membrane, a total membrane length of 10 m has to be integrated into the bioreactor. Three 
membranes with 3.3 m length each are recommended to minimize spatial heterogeneities as 
shown in chapter 7. A noticeable pressure loss accompanied with decreased filtration 
performance is not expectable for a 3.3 m membrane length as shown in Figure 8-1. Reduced 
permeate output due to pressure loss is calculated for various membrane lengths and the 
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settings of RFD based on the principal of pipe flow. Furthermore, for an industrial 
application, sterile single-use bags with integrated membrane modules have to be 
commercially produced. The integration of membranes has to be conducted by the bag 
producer as he guarantees for sterility.   
 
Application of RFD for filamentous organisms or organisms, which tend to grow on 
superficies, would be challenging as membrane blocking is more likely to occur. However, 
based on filtration experiments to determine the transmembrane pressure increase, the 
required membrane area to achieve long-term stability can be calculated and, thus, application 
of RFD should be possible.            
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